Prescribing Patterns of Parkinson’s Disease (Englisch)
- Neue Suche nach: Tomita, N.
- Neue Suche nach: Kanatani, Y.
- Neue Suche nach: Tomita, N.
- Neue Suche nach: Kanatani, Y.
In:
VALUE IN HEALTH
;
16
, 7
;
A629
;
2013
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Prescribing Patterns of Parkinson’s Disease
-
Beteiligte:Tomita, N. ( Autor:in ) / Kanatani, Y. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 16, 7 ; A629
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2013
-
Format / Umfang:A629
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 16, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A323
-
Responsiveness of the EQ-5D in Oncology: A Meta-AnalysisSmith, A. B. / Cocks, K. / Taylor, M. / Parry, D. et al. | 2013
- A324
-
The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical ModellingParham, P. E. / Hughes, D. A. et al. | 2013
- A325
-
Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure: Application in Parkinson’s DiseaseNeine, M. / Briquet, B. / Mokdad, C. E. / Vataire, A. L. / Aballea, S. et al. | 2013
- A326
-
A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)Pennington, B. / Batty, A. J. / Clifton-Brown, E. et al. | 2013
- A327
-
Application of Behavioural Economics to the Understanding of Adherence: Does an Individual’s Time Preference Influence Adherence to Medications?Fargher, E. A. / Morrison, V. / Plumpton, C. O. / Hughes, D. A. et al. | 2013
- A328
-
Quality Criteria for the Development of Implant RegistriesNiederländer, C. S. / Wahlster, P. / Kriza, C. / Schaller, S. U. / Kolominsky-Rabas, P. L. et al. | 2013
- A329
-
Mapping the CCQ onto EQ-5D Scores (Im)Possible?Boland, M. R. / van Boven, J. F. / Rutten-van Mölken, M. P. et al. | 2013
- A330
-
Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids: A Systematic Review and Indirect Treatment ComparisonPanagiotopoulou, N. / Nethra, S. / Karabis, A. / Ahmad, G. / Burls, A. et al. | 2013
- A331
-
Budget Impact of Dienogest in Treating Endometriosis Associated Pelvic Pain in Brazil: A Public Perspective AnalysisFerracini, M. / Nakada, C. P. et al. | 2013
- A332
-
A Cost of a Childbirth with in vitro Fertilization in PolandGóra, K. / Hermanowski, T. / Wrona, W. et al. | 2013
- A333
-
Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in BrazilDecimoni, T. C. / Sansone, D. / Etto, H. / Santos, A. M. / Araújo, G. / Fonseca, E. S. / Fonseca, M. et al. | 2013
- A334
-
Cost Minimization Analysis of the Dienogest Use in Patients with Endometris under Brazilian Public and Private PerspectiveFerracini, M. / Nakada, C. P. et al. | 2013
- A335
-
A Systematic Review of Patient Preferences for Subcutaneous MedicationsRidyard, C. / Dawoud, D. / Hughes, D. A. et al. | 2013
- A336
-
Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice StudyShiroiwa, T. / Saito, S. / Shimozuma, K. / Kodama, S. / Noto, S. / Fukuda, T. et al. | 2013
- A338
-
Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, BrazilFerraz, M. B. / Nardi, E. P. et al. | 2013
- A339
-
Health Outcomes of Female Anabolic-Androgenic Steroid UsersNoone, J. / Blanchette, C. M. et al. | 2013
- A340
-
The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality: An Ecological StudyVeley, K. M. / Malka, E. S. et al. | 2013
- A341
-
Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter TrialStahmeyer, J. T. / Rossol, S. / Bert, F. / Abdelfattah, A. M. / Mauss, S. / Heyne, R. / John, C. / Pape, S. / Schober, A. / Teuber, G. et al. | 2013
- A342
-
Burden of Varicella in Eastern Europe: A Systematic Review and Critical AnalysisYang, H. K. / Song, K. M. / Manoff, S. / Liaw, K. L. / Kuter, B. et al. | 2013
- A343
-
Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United StatesBrogan, A. / Talbird, S. E. / Thompson, J. R. / Kim, Y. A. / Olson, J. / Peterson, J. / Piontkowsky, D. / Pietrandoni, G. et al. | 2013
- A344
-
Examining the Relationship Between Country-Level Factors and Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and UgandaYang, W. / Parisi, M. / Lahue, B. J. / Bishai, D. M. et al. | 2013
- A345
-
Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in RussiaPyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Andreeva, N. et al. | 2013
- A346
-
Counting the Cost of Meningococcal Disease in FranceFaivre, P. / Bénard, S. / Wright, C. / Voisine, J. / Gaudelus, J. et al. | 2013
- A347
-
Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from RussiaAvxentev, N. / Avxentyeva, M. / Platonov, A. / Kolyasnikova, N. / Gridneva, K. / Dolgin, V. / Titkov, A. / Derkach, E. V. et al. | 2013
- A348
-
The Association Between Adherence to Antiretroviral Therapy and Economic Outcomes Among Commercially Insured and Medicaid HIV Patients in the United StatesKorsnes, J. S. / Goodwin, B. / Candrilli, S. D. et al. | 2013
- A349
-
Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, CanadaLachaine, J. / Vachon, M. L. / Lambert-Obry, V. / Beauchemin, C. et al. | 2013
- A350
-
When Treatment Is Mitigated by Adverse Events: The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/RibavirinSullivan, S. / McDermott, C. / Dieterich, D. / Martel-Laferriere, V. / Saab, S. / Gordon, S. et al. | 2013
- A351
-
Cost-Effectiveness Analysis of 3 Candins and Fluconazole in the Treatment of Confirmed Invasive Candidiasis in Adult Non-Neutropaenic Patients in SpainGrau, S. / Pozo, J. C. / Roma, E. / Salavert, M. / Collados, C. / Egea-GarcÃa, M. / Mesa, F. J. / Llevat, N. / Barrueta, A. et al. | 2013
- A352
-
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization ProgramTichopad, A. / Vitova, V. / Roberts, C. S. / Hájek, P. et al. | 2013
- A353
-
A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Costa RicaGarita, M. / Solano, A. / Cuesta, G. / Mould, J. et al. | 2013
- A355
-
Different Discounting Approaches and Their Impact in Economic Evaluation: A Practical Example Using Hepatitis B VaccinationCure, S. / Bianic, F. / Nandini Kahol, D. / Davie, A. et al. | 2013
- A356
-
Economic Analysis of Protease Inhibitors in First-Line Haart in Adult Patients with HIVAvxentyeva, M. / Goryaynov, S. / Rebrova, O. et al. | 2013
- A358
-
Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in RussiaPyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Goryaynov, S. et al. | 2013
- A359
-
COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLANDKaczor, M. P. / Wójcik, R. / Pawlik, D. / Skrzekowska-Baran, I. / Tronczynski, K. et al. | 2013
- A361
-
Patient Satisfaction with HIV Therapies: Focus on Adherence to TreatmentMurray, M. / Dang, N. / Swinburn, P. / Gallop, K. / Lloyd, A. et al. | 2013
- A362
-
Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)Baran, R. W. / Anderson, R. T. / Dietz, B. / Gooch, K. et al. | 2013
- A364
-
United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus MedicationsHogue, S. / Brogan, A. / Goodwin, B. et al. | 2013
- A365
-
Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating TuberculosisStepanenko, A. / Lishchyshyna, O. / Melnyk, Y. et al. | 2013
- A366
-
RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)Paes, B. A. / Li, A. / Mitchell, I. / Lanctot, K. L. et al. | 2013
- A367
-
Estimation of the Number of Cases of Nosocomial Pneumonia in Adults Caused by Gram-Positive Bacteria in Public Hospitals in MexicoGryzbowski, E. / Peniche-Otero, G. / Herrera-Rojas, J. / Bolaños-Cornejo, D. / Huicochea-Bartelt, J. L. / Muciño-Ortega, E. et al. | 2013
- A368
-
The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs: Systematic Review of the LiteraturePérez, M. / Dominguez, J. / Armengol, S. / Paz, S. / Lizán, L. et al. | 2013
- A369
-
Impact of Chronic Pain on Health Care Costs in Chronic Obstructive Pulmonary Disease as Compared to Other Chronic DiseasesMapel, D. / Roberts, M. / Von Worley, A. et al. | 2013
- A370
-
Predicting Health Care Costs in Asthma Using the EQ-5D Index ScoreGu, N. Y. / Raisch, D. W. / Wu, J. / Gai, Y. / Hay, J. W. et al. | 2013
- A371
-
Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal PerspectiveCosta-Scharplatz, M. / Tambour, M. / Henriksson, F. / Ställberg, B. et al. | 2013
- A372
-
Empirical Therapy for Respiratory Tract Infections in an Era of Increasing Antimicrobial Resistance: A Decision and Cost AnalysisBabela, R. et al. | 2013
- A373
-
Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc StudyLeiva-Fernandez, F. / Leiva-Fernandez, J. / Prados-Torres, D. / GarcÃa-Ruiz, A. J. / Barnestein-Fonseca, P. et al. | 2013
- A374
-
Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United StatesCaron, M. / Perrier, L. L. / Acquadro, C. et al. | 2013
- A375
-
The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-FormsSherbourne, C. / Stucky, B. / Edelen, M. O. / Eberhart, N. / Lara, M. et al. | 2013
- A376
-
Patterns in Asthma Medicationtreatment in the United StatesLi, Y. / Suh, K. / Chen, W. / Wei, Z. / Higuchi, K. et al. | 2013
- A377
-
Clinical Effectiveness Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood TransfusionsWalczak, J. / Lipińska, M. / Jarosz, J. / Moczyński, W. / Ślązak, B. / Laczewski, T. et al. | 2013
- A378
-
Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in GreeceMasoura, P. / Murphy, D. R. / Chatzikou, M. / Alexopoulos, S. T. / Magestro, M. et al. | 2013
- A379
-
Pharmacoeconomic Evaluation of Intravenous Ferric Carboxymaltose and Iron Sucrose in Correction of Preoperative Anaemia in Patients Undergoing Major Elective SurgeryGorokhova, S. G. / Ryazhenov, V. V. / Emchenko, I. V. et al. | 2013
- A380
-
Haemophilia A: Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in France: We Should Compare the Cost Per Patient Instead of the Price Per UnitHaarmann, H. / Epstein, J. / Grumel, O. et al. | 2013
- A381
-
A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney DiseaseRizzo, M. / Iheanacho, I. / van Nooten, F. E. / Goldsmith, D. et al. | 2013
- A382
-
Cost-Consequence Analysis of a Treatment Strategy Including Ponatinib Compared to a Treatment Strategy Including Only the 2nd Generation Tyrosine Kinase Inhibitors (2g TKIs), Dasatinib or Nilotinib, in Resistant Patients with Philadelphia Chromosome-Positive (Ph+) Leukemia, in ItalyChiroli, S. / Furneri, G. / Pane, F. et al. | 2013
- A383
-
The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an AnalgesicCawson, M. / Knight, C. / Hirst, M. / Dunlop, W. et al. | 2013
- A384
-
Cost-Effectiveness of Plerixafor (PXF) for Stem Cell Mobilization in Lymphoma (NHL/HL) and Multiple Myeloma (MM) Patients in PolandKaczor, M. P. / Wójcik, R. / Pawlik, D. / Glasek, M. / Pieczonka, A. / Lis, J. et al. | 2013
- A385
-
Full Cost of Plasma from Voluntary Non Remunerated Donors in ItalyZaniolo, O. / Povero, M. / Gandini, G. / Aprili, G. / Eandi, M. et al. | 2013
- A386
-
The Use of Preference Based Measures in Haemophilia: Is the Current Evidence Base Useful for Evidence Based Decision Making?Tolley, K. / Miners, A. / Brazier, J. / Pericleous, L. M. / Sharma, T. / Petersen, J. / Lonergan, T. et al. | 2013
- A387
-
The Impact of Increasing Pain Severity on Impairment of Regular Daily ActivitiesPoole, C. D. / Chambers, C. / Odeyemi, I. / Currie, C. et al. | 2013
- A388
-
Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena: Survey of Rheumatologists in European Union, Brazil, Japan and ChinaNarayanan, S. / Liu, L. et al. | 2013
- A389
-
Appetite Suppressants: A Drug Utilisation StudyTruter, I. et al. | 2013
- A390
-
Cost-Minimization of Mabthera Intravenous Versus Subcutaneous AdministrationBax, P. / Postma, M. J. et al. | 2013
- A392
-
Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United StatesWang, L. / Xie, L. / Li, L. / Wang, Y. / Kariburyo, M. F. / Baser, O. et al. | 2013
- A393
-
An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast CancerChandiwana, D. / Vieira, J. / Granville, J. / McCool, R. / Fleetwood, K. et al. | 2013
- A394
-
A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian CancerEdwards, S. J. / Barton, S. / Thurgar, E. / Wakefield, V. / Karner, C. / Trevor, N. et al. | 2013
- A395
-
Second-Line Treatment of Metastatic Colorectal Cancer (mCRC): A Systematic Literature Review (SLR) and Feasibility Assessment of Conducting Indirect Treatment Comparison (ITC) AnalysisXu, Y. / Martin, A. L. / Ross, S. / Knopf, K. B. / Strand, L. / Iqbal, S. U. / Joulain, F. / Jasso Mosqueda, J. G. / Fahrbach, K. et al. | 2013
- A396
-
Off-Label Trastuzumab Usage in Breast Cancer Patient in TurkeyKockaya, G. / Tanyeri, P. / Buyukokuroglu, M. E. / Yenilmez, F. B. / Durmus, D. / Vural, I. M. / Akbulat, A. / Artiran, G. / Gursoz, H. / Kerman, S. et al. | 2013
- A397
-
Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC): Mean Overall Survival (OS) in a “Better Responders†Patient Population of the Velour TrialJoulain, F. / Naoshy, S. / Chau, I. / Iqbal, S. U. / Bridgewater, J. et al. | 2013
- A398
-
Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Prostate Cancer and Bone Metastasis from a United State Managed Care Organization PerspectiveArellano, J. / Cristino, J. / Chen, K. et al. | 2013
- A399
-
Breast Cancer Screening Program in the Basque Country: Costs and Health Benefits Assessment Through Discrete Event SimulationArrospide, A. / Mar, J. / Comas, M. / Rue, M. / Larrañaga, N. / Acaiturri, T. / Sarriugarte, G. et al. | 2013
- A400
-
Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic LeukemiaWalzer, S. / Tournier, C. / Marino, J. P. / Mueller, E. / Duong, M. et al. | 2013
- A401
-
Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast CancerCampone, M. / Yang, H. / Faust, E. / Kageleiry, A. / Signorovitch, J. / Zhang, J. / Gao, H. et al. | 2013
- A402
-
Costs of Pilot Programs Employing Allied Health Professionals Within the Centers for Population Health and Health DisparitiesWalton, S. / Johnson, T. J. / Li, C. C. / Joyce, B. et al. | 2013
- A403
-
The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients: A Systematic ReviewKourlaba, G. / Relakis, J. / Kontodimas, S. / Holm, M. V. / Maniadakis, N. et al. | 2013
- A404
-
Estimating the Cost of HPV-Related Diseases in Turkey: A Delphi ApproachBakir, M. / Ayhan, A. / Arvas, M. / Kose, M. F. / Gungor, M. / Ortac, F. / Ozgul, N. / Yuce, K. / Ergun, T. / Gungor, E. et al. | 2013
- A405
-
Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and SpainBilir, S. P. / Zhao, Z. / Wehler, E. A. / Munakata, J. / Barber, B. et al. | 2013
- A407
-
Estimation of the Epidemiological and Economic Impact of the Quadrivalent HPV Vaccination in Girls and Boys in SpainBosch, X. / Cortés Bordoy, J. / Gil de Miguel, A. / López Belmonte, J. L. / Bresse, X. / Serip, S. / Nieves, D. et al. | 2013
- A408
-
Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder CancerMarteau, F. / Kornowski, A. / Bennison, C. / Tempest, M. J. / Mariappan, P. / Witjes, J. A. et al. | 2013
- A409
-
Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germanyvan Beurden-Tan, C. / Rosiñol, L. / Diels, J. / Wirth, D. / Chirita, O. / Lahuerta, J. J. / Gaugris, S. / Marsh, S. / San Miguel, J. / Spencer, M. et al. | 2013
- A410
-
Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple MyelomaRochau, U. / Jahn, B. / Qerimi, V. / Kluibenschaedl, M. / Kurzthaler, C. / Conrads-Frank, A. / Willenbacher, W. / Gastl, G. / Siebert, U. et al. | 2013
- A411
-
A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian JurisdictionBerghea, F. / Skoupa, J. / Ciuleanu, T. / Miron, L. / Stanculeanu, D. L. / Jinga, D. / Dediu, M. / Mateescu, D. N. / Hájek, P. / Bradatan, B. et al. | 2013
- A413
-
Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated with Highly and Moderately Emetogenic Cancer Chemotherapy in RussiaKrysanov, I. / Krysanova, V. et al. | 2013
- A414
-
Cost-Effectiveness of First-Line Treatment of Advanced Metastatic Non Small Cell Lung Cancer- A Systematic Review of Economic ModelsEijgelshoven, I. / Verduyn, S. C. / Bhatti, T. / Bexelius, C. / Jansen, J. P. et al. | 2013
- A415
-
Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in JapanShibahara, H. / Shiroiwa, T. / Nakamura, K. / Shimozuma, K. et al. | 2013
- A416
-
Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in SpainCrespo, C. / SeguÃ, M. / Cortés, J. / Lluch, A. / Brosa, M. / Becerra, V. / Chiavenna, S. M. / Gracia, A. et al. | 2013
- A417
-
Economic Activity of Cancer Survivors in PolandMacioch, T. / Hermanowski, T. R. et al. | 2013
- A418
-
Persistence in Patients with Breast Cancer Treated with Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer DatabaseSchmidt, N. / Haas, G. / Mergenthaler, U. / Kostev, K. / Hadji, P. et al. | 2013
- A420
-
Systematic Review of Patient Reported Outcomes in Chronic Myeloid LeukemiaAggarwal, S. / Segal, J. / Topaloglu, H. et al. | 2013
- A421
-
Influence of Anxiety and Depression on 1-Year Health Related Quality of Life in Colorectal Cancer PatientsEscobar, A. / Billbao, A. / Trancho, Z. / Quintana, J. / Sarasqueta, C. / Baré, M. et al. | 2013
- A422
-
HR-QOL Data in the Amnog Early Benefit Assessment: Industry and IQWIG/GBA PerspectiveObradovic, M. / Radicek, S. / Rauland, M. et al. | 2013
- A424
-
Are ICER Threshold Values Malleable? The Case of Life-Extending Cancer Treatments at the End of LifeMoïse, P. / Sweeney, N. / Lie, X. et al. | 2013
- A425
-
A Disease Model of Metastatic Colorectal Cancer Including Multiple Treatment Linesvan Rooijen, E. M. / Uyl-de Groot, C. A. / Punt, C. / Koopman, M. / Coupe, V. M. et al. | 2013
- A427
-
A Novel Algorithm Using Claims Data to Identify Patients with Castration-Resistant Prostate Cancer (CRPC)Gorritz, M. / Thompson, S. F. / Lee, Y. C. / Stern, L. / Penson, D. F. et al. | 2013
- A428
-
Impact of Recommended Pharmaceuticals on Cancer Mortality: Analysis of Real-Life DataWilson, T. / Hamerslag, L. et al. | 2013
- A429
-
Economical Losses Due to Disablementparents Carring for Children with Oncohematological DiseasesGanieva, D. / Zhukovskaya, E. / Spichak, I. et al. | 2013
- A432
-
A Bayesian Multiple Treatment Comparison of Duloxetine, Pregabalin, Gabapentin, Amitriptyline, and Their Combinations for Painful Peripheral Neuropathy Based on Pain Reduction Reported in Clinical TrailsChinthammit, C. / Malone, D. et al. | 2013
- A433
-
The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United KingdomTeneishvili, M. / Marelli, C. / Lee, D. et al. | 2013
- A434
-
Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in South Asian Population Living in Europe: A Systematic ReviewCallejo, D. / DÃaz-Cuervo, H. / Cuervo, J. / Rebollo, P. / Hussain, A. / Hitman, G. A. et al. | 2013
- A436
-
Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with InsulinFoos, V. / Grant, D. / Palmer, J. L. / Varol, N. / Curtis, B. / Boye, K. S. / McEwan, P. et al. | 2013
- A437
-
First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic AnalysisKolbin, A. / Kurylev, A. / Balykina, Y. / Proskurin, M. et al. | 2013
- A439
-
Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan ChildrenRoze, S. / Demessinov, A. / Zeityn, M. / Toktarova, N. / Abduakhassova, G. / Sissemaliev, R. / Karamalis, M. / Dunne, N. / Muratalina, A. / Klots, M. et al. | 2013
- A440
-
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK SettingWillis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Girod, I. / Neslusan, C. et al. | 2013
- A441
-
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK SettingGirod, I. / Willis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Neslusan, C. et al. | 2013
- A442
-
The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in BelgiumJugrin, A. V. / Lamotte, M. / Malfait, M. / Vandebrouck, T. et al. | 2013
- A443
-
Review of Cost of Diabetes Complications in Four European CountriesBeaudet, A. / Grabbi, E. / Maurel, F. / Ramos, M. / Lebioda, A. et al. | 2013
- A444
-
Do Fixed-Dose Combinations Improve Antidiabetic Treatment Compliance? A Study Based on French IMS Lifelink Disease Analyzer DatabaseGrandfils, N. / Le Jeunne, P. / Maillard, C. / Solomiac, A. / Besson, A. et al. | 2013
- A445
-
Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in PolandSobol, E. / Macioch, T. / Krakowiecki, A. / Mrozikiewicz-Rakowska, B. / Mienicka, A. / Mlynarczuk, M. / Kasprowicz, M. / Paweska, J. / Karnafel, W. / Hermanowski, T. R. et al. | 2013
- A446
-
Assessing Quality of Life in Adult Growth Hormone Deficiency: Further Development of the QoL-AGHDAGraham, J. E. / McKenna, S. / Wilburn, J. / Twiss, J. et al. | 2013
- A448
-
Impact of Nocturnal and Daytime Non-Severe Hypoglycaemic Events on People with Diabetes in South AfricaSnyman, J. / Todorova, L. et al. | 2013
- A449
-
The Impact of Memory Problems on Diabetes Treatment in GermanyBrod, M. / Kongso, J. / Bushnell, D. M. et al. | 2013
- A451
-
Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care SystemKececioglu, S. / Ulus, P. / Cukadar, F. / Ozkan, M. / Urganci, B. et al. | 2013
- A453
-
How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?Deger, C. C. / Tuna, E. / Ozdemir, Z. / Ozel, M. O. / Parali, E. / Sumer, F. / Yilmaz, Z. S. et al. | 2013
- A455
-
Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy CandidatesLabban, M. / Izmirlieva, M. / Ando, G. et al. | 2013
- A456
-
2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDSDehnen, J. / Schmoeller, M. et al. | 2013
- A457
-
Pricing of “Follow-On†Drugs and Competition Within Pharmaceutical Classes: Evidence from Germany 1993-2008Mueller, M. T. / Frenzel, A. et al. | 2013
- A458
-
Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 CountriesDavey, P. et al. | 2013
- A459
-
EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement DecisionsHogue, S. / Hollis, K. / McLeod, L. / Brogan, A. / Heyes, A. E. et al. | 2013
- A460
-
How Does Prescription of Generic Drugs Spread Out?: Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals NationwideShimizu, S. / Ishikawa, K. B. / Ikeda, S. / Fushimi, K. et al. | 2013
- A461
-
A Systematic Evaluation of Drug-Drug Interactions in Prescriptions; Facts and ComparisonsAhmad, M. / Arshad, W. / Usman Minhas, M. et al. | 2013
- A462
-
Current Status and Evidence of Effects of E-Prescribing Implementation in United Kingdom, Italy, Germany, Denmark, Poland and United StatesHermanowski, T. R. / Kowalczyk, M. / Szafraniec-Burylo, S. I. / Krancberg, A. N. / Pashos, C. L. et al. | 2013
- A463
-
Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in HungaryCs. Horváth, Z. / Molics, B. / �goston, I. / Sebestyén, A. / Boncz, I. et al. | 2013
- A464
-
Variability in Publically-Prescribed Drug Costs: The Role of Region, Age and GenderO Céilleachair, A. J. / Woods, N. / O’Sullivan, K. / Kenneally, M. et al. | 2013
- A465
-
Cost-Effectiveness of an Interface Geriatric Intervention: Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study (AMIGOS)Tanajewski, L. / Franklin, M. / Gkountouras, G. / Berdunov, V. / Edmans, J. / Conroy, S. / Bradshaw, L. / Gladman, J. / Elliott, R. A. et al. | 2013
- A466
-
Pharmaceutical Expenditure, Clinical Outcomes and Expenditures on Other Health ServicesSiskou, O. / Galanis, P. / Tsavalias, K. / Kalogeropoulou, M. / Kaitelidou, D. / Pasaloglou, S. / Schneider, M. / Liaropoulos, L. et al. | 2013
- A468
-
Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in SerbiaMedic, G. / Baltezarevic, D. / Novakovic, T. et al. | 2013
- A469
-
Acceptability of Indirect Evidence to Support Drug Reimbursement in AustraliaO’Leary, B. A. / McKenna, S. J. / Cheng, Y. Y. / McElroy, H. J. et al. | 2013
- A471
-
Investigating Safety-Appraoch in Saudi Arabia Ministry of Health HospitalsAlkelya, M. A. / Haleem, R. M. et al. | 2013
- A472
-
Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?Nijhuis, T. / Haigh, J. / Van Engen, A. et al. | 2013
- A473
-
A Systematic Comparison of Market Access and Reimbursement Pathways for Diagnostic Tests in Germany, United Kingdom and the United StatesWalzer, S. / Gartemann, J. et al. | 2013
- A474
-
Pricing and Reimbursment of Pharmaceuticals in IranMoradi, M. et al. | 2013
- A475
-
A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)Charokopou, M. / Heeg, B. / Schoeman, O. / Mueller, S. / Tempest, M. J. / Schlagmüller, S. C. / Wilke, T. et al. | 2013
- A476
-
Point of Care Tests: The Long and Winding Road to ReimbursementHogue, S. / Brogan, A. / Heyes, A. et al. | 2013
- A478
-
Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies from 2000 to 2012 in TurkeyKockaya, G. / Daylan Kockaya, P. / Ergin, G. et al. | 2013
- A479
-
Workshop in Pharmacoeconomics: An Italian Experience of Multi-Stakeholder Hta ConsensusCicchetti, A. / Gasbarrini, A. / Ruggeri, M. / Sacchini, D. / Lanati, E. P. et al. | 2013
- A480
-
Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs ProgramMaguire, B. / Tilden, D. et al. | 2013
- A481
-
Analysis of Transparency Amongst International Health Technology Assessment OrganizationsJebrail, F. / Duong, M. / Shum, D. et al. | 2013
- A482
-
Which Should Be the Correct NMA to Be Used? A Review of HTA RecommendationsSolozabal, M. / Roset, M. / Rojas-Farreras, S. / González-Rojas, N. / Gil, A. et al. | 2013
- A483
-
Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBACJaksa, A. / Ho, Y. S. / Daniel, K. et al. | 2013
- A484
-
Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)Lebioda, A. / Gasche, D. / Dippel, F. W. / Plantör, S. et al. | 2013
- A485
-
Systematic Review on Use of Economic Evidence by Clinical GuidelinesAggarwal, S. / McGrane, M. / Topaloglu, H. et al. | 2013
- A486
-
Guidance for Partnership Working Between CatSalut and the Pharmaceutical IndustryGilabert, A. / Espinosa, C. / Mora, R. / Santos, J. et al. | 2013
- A487
-
Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?Kornfeld, A. / Schroeder, M. / Toumi, M. et al. | 2013
- A489
-
The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)Wahlster, P. / Niederländer, C. S. / Kriza, C. / Kolominsky-Rabas, P. L. et al. | 2013
- A490
-
How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?Patel, P. / Donze, B. / Zaganelli, D. et al. | 2013
- A491
-
Review of Economic Principles of Branded “Me-Too†Drugs MarketHren, R. et al. | 2013
- A492
-
Understanding the Effect of Clostridium Difficile Infection on Hospital Mortality in England, the Netherlands, and SpainWasserman, M. / Jones, C. / Roberts, G. / Latif, F. et al. | 2013
- A494
-
Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in ItalyLa Torre, G. / Miele, L. / Mannocci, A. / Saulle, R. / Giraldi, G. / Unim, B. / Ursillo, P. / Semyonov, L. / Colamesta, V. / Melcarne, R. et al. | 2013
- A495
-
Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD)Murray-Thomas, T. / Dedman, D. / Canavan, C. / West, J. / Card, T. et al. | 2013
- A496
-
An Economic Evaluation Comparing ePTFE Covered Stent-Grafts Configured for Tips with Bare Metal Stents in Procedures for the Treatment of Portal Hypertension ComplicationsBurke, M. / Hacking, N. / Wright, M. / Iqbal, K. / Craig, J. et al. | 2013
- A497
-
Crohn’s Disease: An Economic Assessment of Biological Drugs in ItalyCicchetti, A. / Gasbarrini, A. / Ruggeri, M. et al. | 2013
- A499
-
Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s DiseaseWilburn, J. / McKenna, S. / Twiss, J. / Kemp, K. / Campbell, S. et al. | 2013
- A500
-
Systematic Literature Review in Moderate to Severe Ulcerative ColitisHuisman, E. / Medic, G. / Eijgelshoven, I. / Weijers, L. / Karabis, A. et al. | 2013
- A501
-
Indirect Comparison of the Effect of Biologics in Patients with Psoriasis; A Meta-Analysis of Randomized, Double Blind Clinical Trials in Bayesian FrameworkBrodszky, V. / Mo, M. / Gulacsi, L. / Baji, P. / Balogh, O. / Péntek, M. et al. | 2013
- A502
-
Children with Atopic Dermatitis: Monitoring a French Cohort Over a Nine-Year PeriodTaieb, C. et al. | 2013
- A503
-
Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular LensSamiian, A. / Carones, F. et al. | 2013
- A504
-
Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United StatesTencer, T. / Li, S. / Zhang, F. et al. | 2013
- A505
-
Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in the United KingdomBetts, K. A. / Sundaram, M. / Mughal, F. / Yan, S. Y. / Signorovitch, J. / Wang, K. / Wu, E. Q. et al. | 2013
- A506
-
The Cost-Effectiveness of Bimatoprost 0.03%/Timolol 0.05% Preservative-Free Fixed Combination Compared with Dorzolamide/Timolol Preservative-Free Fixed Combination and 2-Bottle Unfixed Combinations for the Treatment of Primary Open-Angle Glaucoma in the United KingdomHirst, A. / Almond, C. / Brereton, N. J. / Shergill, S. / Wong, W. et al. | 2013
- A507
-
Cost-Effectiveness of Sequences of Biologic Treatments for Moderate-To-Severe Psoriasis in FinlandAsseburg, C. / Valgardsson, S. / Soini, E. J. et al. | 2013
- A508
-
The Burden Imposed by Atopic Dermatitis on Families: Creation of a Specific QuestionnaireTaieb, C. / Branchoux, S. et al. | 2013
- A509
-
Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors: The Equade StudyLeveziel, N. / Joubert, M. / Hermans, M. / Moser, E. / Le Picard, S. / Maurel, F. et al. | 2013
- A511
-
Adherence by Spanish Retinologists to the Guidance for the Management of Patients with Wet Age-Related Macular DegenerationColomé, A. / Balaña, M. / Ruiz Moreno, J. M. / Roura, M. et al. | 2013
- A512
-
High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting: Treatment Patterns and OutcomesDegli Esposti, L. / Sangiorgi, D. / Buda, S. et al. | 2013
- A513
-
Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant?Ibrahim, N. / Norris, L. / O’Toole, S. / Gleeson, N. et al. | 2013
- A514
-
Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: A Systematic Literature ReviewClaflin, A. B. / Liu, X. / Phatak, H. et al. | 2013
- A515
-
Anticoagulant Use in Hospitalized Patients with Acute Venous Thromboembolism in the United StatesLiu, X. / Xie, L. / Phatak, H. / Mardekian, J. / Tan, W. / Baser, O. / Schneider, R. F. / Ramacciotti, E. et al. | 2013
- A518
-
A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular DiseaseCorbo, M. / Beccagutti, G. / Manda, B. et al. | 2013
- A519
-
Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in RussiaRyazhenov, V. V. / Gorokhova, S. G. et al. | 2013
- A520
-
The Burden of Resistant Hypertension in 5 European CountriesSapoval, M. / Hale, B. C. / Armstrong, S. / Da Deppo, L. / Hertz, D. / Briggs, A. et al. | 2013
- A521
-
Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)Berger, A. / LaPensee, K. / Oster, G. et al. | 2013
- A523
-
Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis TreatmentsSmolen, H. J. et al. | 2013
- A524
-
Cost-Effectiveness of Apixaban Versus Standard of Care for the Prevention of Stroke: An Analysis of Patients with Atrial Fibrillation in GreeceAthanasakis, K. / Arzoumanidou, D. / Karampli, E. / Armelidou, E. / Giovas, P. / Petrikkou, E. / Kyriopoulos, J. et al. | 2013
- A525
-
Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in ItalyCapri, S. / Veneziano, M. / Ricciardi, W. G. / D’Ausilio, A. / Pedone, M. P. / Bianchi, C. et al. | 2013
- A526
-
The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in AustraliaTilden, D. / Germanos, P. / Gordon, J. / Tocchini, L. et al. | 2013
- A527
-
The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in BelgiumJugrin, A. V. / Caekelbergh, K. / Vanacker, J. / Vancauwenberghe, L. / Lamotte, M. et al. | 2013
- A528
-
Cost-Effectiveness Analysis of Ivabradine in Chronic Heart Failure in the Polish SettingBorowiec, L. / Faluta, T. / Filipiak, K. J. / Niewada, M. / Wrona, W. et al. | 2013
- A529
-
Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the NetherlandsStevanovic, J. / Pompen, M. / Le, H. H. / Rozenbaum, M. H. / Postma, M. J. et al. | 2013
- A530
-
Cost-Utility Analysis of Coronary Artery Calcium Score to Guide Statin Therapy in Patients with Elevated C-Reactive Protein and Low LDL Cholesterol LevelsSilva Miguel, L. / Ferreira, A. M. et al. | 2013
- A531
-
Real World Resource Use Associated with Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement SurgeryAwad, W. / Mathur, A. / Baldock, L. / Oliver, S. / Kennon, S. et al. | 2013
- A532
-
Effects of the Occurrence of a First Cardiovascular Event on Statin Adherence in Type 2 Diabetes: A Matched Cohort Designde Vries, F. M. / Denig, P. / Vegter, S. / Bos, H. J. / Postma, M. J. / Hak, E. et al. | 2013
- A533
-
The Relation Between the Modified Rankin Scale (mRS) Scores and Utility Weights: Results from a Survey Among Community Dwelling Long Term Stroke SurvivorsGreenberg, D. / Ginsberg, G. / Ziv, A. / Litmanovitch-Goldstein, D. / Tanne, D. / Chodick, G. / Balicer, R. D. / Dankner, R. et al. | 2013
- A534
-
A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive PatientsHong, J. M. / Kim, E. G. / Min, K. / Min, J. / Shin, K. / Yang, B. M. et al. | 2013
- A535
-
Coronary Artery Disease, Diabetes, and Health-Related Quality of Life: Findings of a Cohort Study from IndiaShah, B. S. / Deshpande, S. S. et al. | 2013
- A536
-
Adherence to Warfarin Treatment in Brazil: Systematic Review of the LiteratureFeijo, L. F. / Clark, O. A. / Monteiro, R. C. / Fujii, R. K. / Donato, B. M. / Bernardino, G. D. / Barbieri, D. E. / Mould, J. / Manfrin, D. F. et al. | 2013
- A537
-
Cross-Country Comparison of Prescribing Patterns Versus Portugal and Potential Cost-SavingsCosta, S. / Guerreiro, J. P. / Baptista, A. / Teixeira, I. / Torre, C. et al. | 2013
- A538
-
Analysis of Re-Hospitalisations for Stroke and Transient Ischemia Recurrence and Associated Costs in the Burgundy Region in FranceMarty, R. / Jouaneton, B. / Giroud, M. / Mougin, P. / Roze, S. et al. | 2013
- A539
-
The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for GermanyMennicken, R. / Hentschker, C. et al. | 2013
- A540
-
Divergence of HTA Decisions Across Countries: Case Analysis of IvabradineThivolet, M. / Rémuzat, C. / Kornfeld, A. / Toumi, M. et al. | 2013
- A541
-
Results from the “Autor†Study, a European Observational Study in Pediatric Patients with Attention-Deficit/Hyperactivity DisorderHaynes, V. / Lopez-Romero, P. / Anand, H. et al. | 2013
- A542
-
Comparative Efficacy and Metabolic Side Effects of Lurasidone for the Management of Acute Schizophrenia: A Systematic Literature Review and Mixed Treatment Comparison with First and Second Generation AntipsychoticsGuelfucci, F. / Watt, M. / Vimont, A. / Roïz, J. / Cadi-Soussi, N. et al. | 2013
- A543
-
Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform StudySaragoussi, D. / Haro, J. M. / Boulenger, J. P. / Jönsson, B. / Knapp, M. / Caillou, H. / Chalem, Y. / Milea, D. / François, C. et al. | 2013
- A544
-
Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Post-Traumatic Stress Disorder in the United StatesXie, L. / Dysinger, A. H. / Wang, L. / Du, J. / Huang, A. / Baser, O. et al. | 2013
- A545
-
Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature ReviewWalczak, J. / Augustyńska, J. / Miernik, K. / Stelmachowski, J. / Pieniazek, I. / Obrzut, G. / Pogroszewska, A. / Szkultecka-Debek, M. / Paulic, G. / Maric, D. et al. | 2013
- A546
-
Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in SchizophreniaBorsi, A. / Takacs, P. / Feher, L. et al. | 2013
- A547
-
How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?Massetti, M. / Vataire, A. L. / Cristeau, O. / Toumi, M. / Aballea, S. et al. | 2013
- A549
-
Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting MethylphenidateCurtice, T. G. / Greven, P. / Yeaw, J. / Sikirica, V. / Chen, Y. J. / Setyawan, J. / Makin, C. et al. | 2013
- A550
-
Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in IndiaNegi, H. / Raval, A. / Malay, M. et al. | 2013
- A551
-
Developing an Individualized E-Health Decision Support System for Dementia Treatment and Care: The FP7 EU-Project E-Health Monitor (EHM)Schaller, S. U. / Kriza, C. / Niederländer, C. / Wahlster, P. / Kolominsky-Rabas, P. L. et al. | 2013
- A552
-
Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in Swedish Patients with SchizophreniaDepont, F. / Rouleau, A. / Osby, U. / Sobocki, P. / Milea, D. et al. | 2013
- A553
-
Impact of Autism Spectrum Disorders on the Family – A National PerspectiveVohra, R. / Madhavan, S. / Sambamoorthi, U. et al. | 2013
- A554
-
The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis PatientsDoddapaneni, S. / Khera, K. / Prabhu, V. A. / Nagappa, A. N. / Rau, N. R. et al. | 2013
- A556
-
Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary CareSaramago, P. / Weatherly, H. / Manca, A. / Sculpher, M. J. / MacPherson, H. et al. | 2013
- A558
-
Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care SettingDerkach, E. V. / Avxentyeva, M. V. / Omelyanovsky, V. V. et al. | 2013
- A560
-
Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected StudiesWladysiuk, M. / Bebrysz, M. / Rutkowski, J. / Haldas, M. / Fedyna, M. et al. | 2013
- A561
-
Biological Treatment Patterns and Associated Costs for Patients with Rheumatoid Arthritis in TaiwanWu, C. H. / Chuang, P. Y. / Tang, C. H. et al. | 2013
- A562
-
Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa TherapyRyazhenov, V. V. / Emchenko, I. V. et al. | 2013
- A564
-
Current and Future Strategy for Osteoporosis Screening and Diagnostics: Cost-Effectiveness of Frax with or without Pulse-Echo Ultrasound Measurement of Bone Mineral Density and DXA on DemandAsseburg, C. / Riekkinen, O. / Karjalainen, J. K. / Kröger, H. / Soini, E. J. et al. | 2013
- A566
-
Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home VisitsSzafraniec-Burylo, S. I. / Orlewska, E. / Rupinski, R. / Filipowicz-Sosnowska, A. et al. | 2013
- A567
-
Persistence & Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary: A Retrospective Cohort StudyLakatos, P. / Tóth, E. / Cina, Z. / Lang, Z. / Psachoulia, E. / Intorcia, M. et al. | 2013
- A568
-
Are Patients’ Preferences for Osteoporosis Drug Treatment Transferable Between Countries? Results from a Discrete-Choice Experiment Conducted in Two European CountriesHiligsmann, M. / Dellaert, B. / Dirksen, C. / Van der Weijden, T. / Goemaere, S. / McGowan, B. / Reginster, J. Y. / Watson, V. / Boonen, A. et al. | 2013
- A569
-
Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients: Comparison with Matched ControlsPignot, M. / DiBonaventura, M. et al. | 2013
- A570
-
Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment: Results of a Survey Among French PatientsFagnani, F. / Duburcq, A. / Woronoff, A. S. / Chauvin, P. / Cukierman, G. / Tropé-Chirol, S. / Joubert, J. M. / Bertin, P. et al. | 2013
- A571
-
Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European UnionNarayanan, S. / Baskett, A. / Lu, Y. / Hutchings, R. et al. | 2013
- A572
-
Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients: A French National Claims Database Analysis Over the Period 2009-2011Fautrel, B. / Laurendeau, C. / Joubert, J. M. / Cukierman, G. / Gourmelen, J. / Fagnani, F. et al. | 2013
- A573
-
The Resource Use Related to Hip Fractures Based on Data from ICUROSWintzell, V. / IvergÃ¥rd, M. / Tankó, L. B. / Barghout, V. / Svedbom, A. / Alekna, V. / Bianchi, M. L. / Clark, P. / DÃaz Curiel, M. / Dimai, H. P. et al. | 2013
- A574
-
The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in GermanySroczynski, G. / Esteban, E. / Engel, J. / Hillemanns, P. / Petry, K. U. / Krämer, A. / Schnell-Inderst, P. / Mühlberger, N. / Siebert, U. et al. | 2013
- A575
-
Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung CancerLuaces, P. / Sánchez, L. / Ballesteros, J. / GarcÃa, B. / RodrÃguez, P. C. / Viada, C. / Popa, X. / Crombet, T. / Lage, A. et al. | 2013
- A576
-
Review of Meta-Analysis Methods for Multinomial DataBennison, C. / van Beurden-Tan, C. / Buyukkaramikli, C. / Heeg, B. et al. | 2013
- A577
-
Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology: A Willingness-To-Participate StudyPotthoff, P. / Brown, C. / Güther, B. / Eichmann, F. et al. | 2013
- A578
-
Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and WalesRighetti, C. / Lebmeier, M. / Pennington, B. / Brereton, N. J. et al. | 2013
- A579
-
Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall: A Systematic ReviewThorn, J. / Noble, S. / Moore, T. / Hollingworth, W. et al. | 2013
- A580
-
The Economic Footprint of the Greek Pharmaceutical IndustryTserkezis, E. / Paratsiokas, N. / Tsakanikas, A. / Athanasiadis, A. et al. | 2013
- A581
-
Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United KingdomDemuth, D. / Nasuti, P. / Richards, C. / Gray, L. / Price, L. / Magestro, M. et al. | 2013
- A582
-
Evaluation of Dissemination of Brazilian Network for Health Technology Assessment (REBRATS)Gonçalves, L. / Souza, K. M. / Elias, F. T. et al. | 2013
- A583
-
From Clinical Trial to Real-World Evidence: A Systematic Approach to Identifying Data Sources for Observational ResearchParasuraman, B. / Tomic, K. S. / Winchester, C. C. / Westergaard, M. / Johansson, S. et al. | 2013
- A585
-
Variance Reduction Through Antithetic Variates as a Means of Developing Complex VBA Models with Reasonable Computation TimesBennett, H. / Tetlow, A. P. / McEwan, P. et al. | 2013
- A587
-
The Role of Simulation Modeling in Planning Long-Term Clinical Trials in Type 2 DiabetesFoos, V. / Grant, D. / Palmer, J. L. / Lamotte, M. / McEwan, P. et al. | 2013
- A589
-
Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung CancerStenehjem, D. / Jiao, T. / Rhien, T. / Bellows, B. K. / Kaldate, R. R. / Jones, J. / Brixner, D. et al. | 2013
- A590
-
A De Novo Economic Model to Assess the Cost and Quality of Life Consequences of an Intervention for Levodopa Induced Dyskinesia Amongst Patients with Parkinson’s DiseaseBhattacharyya, S. / Sacco, P. / Shirore, R. M. / Sonathi, V. / Thomas, S. et al. | 2013
- A591
-
Appropriate Evidence Sources for Populating Decision Analytic Models Within Health Technology Assessment (HTA): A Systematic Review of HTA Manuals and Health Economic GuidelinesZechmeister-Koss, I. / Schnell-Inderst, P. / Zauner, G. et al. | 2013
- A592
-
The Role of Half-Cycle Correction in the Models Used for Health Technology AssessmentNemeth, B. / Vincziczki, . et al. | 2013
- A594
-
A Bayesian Dynamic Model of Asthma in the Real LifeAmzal, B. / Timmaraju, V. / Castelnuovo, E. / Boucot, I. / Pribil, C. / Nachbaur, G. et al. | 2013
- A595
-
Patient Preferences in the Choice of Disease Modifying Drugs for Multiple SclerosisBergmann, A. / Lang, M. / Bischoff, C. / Schicklmaier, P. / Schiffhorst, G. / Nolting, H. D. / Rellecke, J. / Kunz, E. et al. | 2013
- A596
-
Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in MalaysiaLim, Y. W. / Shafie, A. A. / Hassali, M. A. / Chua, G. N. et al. | 2013
- A598
-
Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand†(Dash) QuestionnaireGolicki, D. / Krzysiak, M. / Strzelczyk, P. et al. | 2013
- A599
-
Validity of QOL Impact Attributions to Specific Diseases: A Multitrait-Multimethod ComparisonWare, J. E. / Guyer, R. et al. | 2013
- A600
-
Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials: A Content Validity and Psychometric Performance ReviewHumphrey, L. / Heron, L. / Pilling, C. / Holloway, L. / Højbjerre, L. / Strandberg-Larsen, M. / Hansen, B. B. et al. | 2013
- A602
-
A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)Simon, M. / Sweeney, E. / Moravec, H. et al. | 2013
- A603
-
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X SyndromeBailey, D. / Raspa, M. / Wheeler, A. et al. | 2013
- A604
-
Using Mobile Technology (mHealth) to Develop the Value Story for New Drugs, Devices and Therapies: Optimising User Engagement and Addressing Payer ConcernsTran, J. B. / Hugh-Jones, C. et al. | 2013
- A605
-
Development of a Questionnaire to Evaluate Food-Related Well-BeingGuillemin, I. / Allaert, F. A. / Arnould, B. / Capuron, L. / Dupuy, A. / Ginon, E. / Lecerf, J. M. / Prost, M. / Rogeaux, M. / Urdapiletta, I. et al. | 2013
- A606
-
Differential Item Functioning in a Satisfaction Item BankCampillo-Ã�lvarez, . / RodrÃguez-Aguilella, A. / Castejón, N. / Cuervo, J. / Rebollo, P. et al. | 2013
- A607
-
The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity DisorderMeyers, O. I. et al. | 2013
- A608
-
Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life EstimatesBujkiewicz, S. / Thompson, J. / Sutton, A. / Cooper, N. / Harrison, M. / Symmons, D. P. / Abrams, K. R. et al. | 2013
- A610
-
Adjusting for Treatment Switching in Clinical Trials When Only Summary Data Are Available – An Evaluation of Potential MethodsBoucher, R. / Abrams, K. R. / Crowther, M. J. / Lambert, P. C. / Wailoo, A. J. / Latimer, N. R. et al. | 2013
- A612
-
Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence LevelsSchopohl, D. / Berger, K. / Schramm, W. et al. | 2013
- A613
-
Proposal of Economic Evaluation Guideline in JapanFukuda, T. / Akazawa, M. / Fukuda, H. / Igarashi, A. / Ikeda, S. / Ishida, H. / Kobayashi, M. / Moriwaki, K. / Noto, S. / Sakamaki, H. et al. | 2013
- A614
-
Systematic Review Approaches for HTA: Horses for Courses?Kenworthy, J. / Langham, J. / Chetty, M. et al. | 2013
- A615
-
Should There Be an Option to “Unrefer†Nice Single Technology Appraisals: Case Study of Aripiprazole for Bipolar I Disorder in AdolescentsUttley, L. / Kearns, B. / Stevenson, M. et al. | 2013
- A616
-
How Can Health Economic Assessment Methods Help Decision Making in Portfolio DevelopmentAkpo, H. / Popa, C. / Saka, . et al. | 2013
- A617
-
The Importance of Sensitivity Analyses in Health Technology AssessmentsHren, R. et al. | 2013
- A618
-
Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova StudyMartikainen, J. A. / Kautiainen, H. / Väätäinen, S. / Välimäki, T. / Hongisto, K. / Hallikainen, I. / Sivenius, J. / Soininen, H. / Koivisto, A. et al. | 2013
- A619
-
Practice of Cerebroprotectors Consumption in UkraineKuznetsov, I. / Iakovlieva, L. / Ribka, A. / Vasileva, A. / Kyrychenko, O. et al. | 2013
- A621
-
The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in GreeceTzovolou, K. / Geitona, M. et al. | 2013
- A622
-
Cost-Effectiveness of Somatropin Administration with Increased Adherence Due to Monitoring Compared to Non-Monitored Administration in Patients with Growth Hormone DeficiencyVitova, V. / Tichopad, A. et al. | 2013
- A623
-
Cost-Effectiveness Analysis of Lacosamide Compared with Standard of Antiepileptic Care Based on Clinical Practice DataVocelka, M. / Klimes, J. / Dolezal, T. / Foitova, H. et al. | 2013
- A624
-
Treatment Adherence and Costs in Multiple Sclerosis: A Narrative Review of the LiteraturePaz, S. / Comellas, M. / Lizán, L. et al. | 2013
- A625
-
Cultural Adaptation and Validation to Spanish of the “MS Treatment Concerns Questionnaire-MSTCQâ€Galera, J. / Munteis, E. / Navarro, G. / Meca, J. / Maestre, A. / Perez, A. / Gracia, J. / Pato, A. et al. | 2013
- A626
-
Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS): Operational Setup for a Multi-Country, Multi-Center StudyApecechea de Scheffer, M. / Faber, S. / Potthoff, P. / Eichmann, F. et al. | 2013
- A627
-
Additional Clinical Benefit for Patient Relevant Endpoints: Investment Disincentives by AMNOG in the Example of Parkinson’s DiseaseWalzer, S. / Holbein, B. et al. | 2013
- A628
-
Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom: A CPRD-Based StudyBineau, S. / Guelfucci, F. / Neine, M. / Aballea, S. / Milea, D. et al. | 2013
- A629
-
A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United StatesJiao, T. / Liou, T. G. / Young, D. / Brixner, D. et al. | 2013
- A631
-
In-Patient Hospitalizations for Chronic Kidney Disease in the United StatesAggarwal, S. / Topaloglu, H. et al. | 2013
- A632
-
Cost and Cost-Effectiveness of Treating Urgency Stress Incontinence-Results from a Randomized Controlled TrialKafri, R. / Greenberg, D. / Shames, J. / Novack, L. / Melzer, I. et al. | 2013
- A633
-
Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United KingdomMaman, K. / Neine, M. / Briquet, B. / Nazir, J. / Odeyemi, I. A. / Hakimi, Z. / Garnham, A. / Aballéa, S. et al. | 2013
- A634
-
The Impact of Sacral Neuromodulation on EQ-5D Index Scores and Costs to Manage Overactive BladderHinnenthal, J. / Siegel, S. / Noblett, K. / Mangel, J. / Bird, E. T. / Griebling, T. L. / Comiter, C. et al. | 2013
- A635
-
Antibiotic Utilization in Complicated Urinary Tract Infection in a Tertiary Care Teaching Hospital in South IndiaNair, S. / Mathew, J. / Palaye, M. / Faryabi, R. / Shetty, P. / Shivshankar, K. / Thunga, G. / Vijayanarayana, K. et al. | 2013
- A637
-
ISPOR 16th Annual European Congress Disclosure Information| 2013
- A649
-
ISPOR 16th Annual European Congress Author Index| 2013
- A665
-
Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto EconómicoContreras, I. / Lopez-Perez, A. / Mendez, G. F. / Mejia-Arangure, E. et al. | 2013
- A666
-
Effect of Health Spending, Income Inequality and Margination Index on the Efficiency of the Health System in MexicoPinzon Florez, C. E. / Reveiz, L. / Idrovo, A. J. / Reyes, H. / Diaz de Leon, C. et al. | 2013
- A667
-
Eficácia E Segurança De Ranibizumabe E Bevacizumabe No Tratamento De Degeneração Macular Relacionada a IdadeSaturnino, L. T. / Silveira, M. R. / Guerra Junior, A. A. / Acurcio, F. D. et al. | 2013
- A668
-
Implications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs: The Case of Trastuzumab in Seven Latin American CountriesPichon Riviere, A. / Garay, U. / Augustovski, F. / Vallejos, C. / Huayanay, L. / Navia, M. D. / RodrÃguez, A. / Oliveira, C. / Andrade, C. J. / Buendia, J. A. et al. | 2013
- A669
-
¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios CientÃficos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?Márquez Cruz, M. / Peralta Bácenas, L. A. / Ibarra Cázares, A. E. / Rodriguez Mendoza, M. M. / Pizarro Castellanos, M. / Soto Molina, H. et al. | 2013
- A670
-
Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012Servan-Mori, E. et al. | 2013
- A671
-
A Multi-National Survey Assessing the Relationship Between Prophylaxis Treatment and Health-Related Quality of Life Among Severe Hemophilia a Patients in Latin AmericaPerez Bianco, P. R. / Berges, A. / Linares, A. / Moreno, B. / Arvizu, J. / Brabata, C. / Xiong, Y. / Ito, D. et al. | 2013
- A674
-
Fatores Associados À Compra De Medicamentos Em BrasÃlia: Uma Análise Econométrica Com Dados Transversais De Base PopulacionalAndrade, C. H. / Wichmann, R. M. / Galvao, T. F. / Pereira, M. G. / Silva, M. T. et al. | 2013
- A675
-
Crescimento De Óbitos Pós Partos Cesarianos No Brasil Versus Partos NormaisDrago, S. / Ferreira, C. N. / Salles, G. R. / Paloni, E. D. / Santana, C. F. / Souza, C. / Bonachela, F. / Abreu, A. A. et al. | 2013
- A676
-
Análisis De Costo-Efectividad De Los Profesionales De Enfermeria Con Experiencia Laboral En Uci Versus Sin Experiencia Laboral En El Error De La Medicación Parenteral En Pacientes Adultos Hospitalizados En UciBeiza, C. / Orrego, N. / Padilla, M. F. / Arriagada, M. J. / Catalan, J. / Fau, C. / Nasabun, V. et al. | 2013
- A677
-
Assessment of Adverse Events By Using Trigger Tools in Surgery Department of an Indian Tertiary Care Teaching HospitalVilakkathala, R. / Mallayasamy, S. / Konduru, S. / Rodriques, G. / Manchanapalli, P. / Rao, A. B. et al. | 2013
- A678
-
Comparación Del Trabajo En Equipo En Salas De CirugÃa Entre Un Hospital Privado Y Uno Público De Bogotá, D.CAmaya Arias, A. C. / Eslava-Schmalbach, J. / Barajas Sierra, R. et al. | 2013
- A679
-
Exploring Income Inequality in Self-Reported Health Status in Chile After the Health Care Reform of 2005Cabieses, B. / Espinoza, M. A. et al. | 2013
- A680
-
A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar BrasileiroTanaka, F. H. / Franco, S. et al. | 2013
- A681
-
Access to Medicines Index: Measuring How Well Countries Provide Access to MedicinesShankar, R. / Hickson, S. / Gorokhovich, L. et al. | 2013
- A682
-
O Uso De Temozolomida No Tratamento De Astrocitoma De Baixo Grau – Câncer No CérebroGomes, R. M. / Ribeiro Júnior, N. G. / Costa, J. O. / Júnior, A. A. / Acurcio, F. A. et al. | 2013
- A684
-
Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil: Results from a 12-Month Retrospective Analysis of an Administrative DatabasePaloni, E. D. / Ferreira, C. N. / Asano, E. / Santana, C. F. / Pereira, M. L. et al. | 2013
- A685
-
Análisis De Costo-Efectividad De Erlotinib En El Tratamiento De Pacientes Con Cáncer Pulmonar De Células No Pequeñas, CPCNP, Con Mutación Del Gen EGFR+, En Colombiaparada Vargas, L. A. / Barbosa, D. A. et al. | 2013
- A686
-
Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe: Acesso E Impacto Econômico Em Um Hospital UniversitárioUngari, A. Q. / Pereira, L. R. / Nunes, A. A. / Peria, F. M. et al. | 2013
- A687
-
Comparación Indirecta De La Efectividad De La Combinación De Hipoglucemiantes Asociados a Metformina En Pacientes Diabéticos Tipo 2Sanchez, O. / Romero, M. et al. | 2013
- A688
-
Direct Costs of Type 2 Diabetes in Mexico from the Public Health Care Sector PerspectiveChatzitheofilou, I. / Babineaux, S. M. / RamÃrez-Gámez, J. / McDonell, A. / Vega-Hernandez, G. et al. | 2013
- A689
-
A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in MexicoTeschemaker, A. R. / Neslusan, C. / Puig, A. / Valencia, A. / Johansen, P. / Willis, M. et al. | 2013
- A690
-
Impacto De La Diabetes Sobre La Productividad En ArgentinaAsteazaran, S. / Elgart, J. / Gagliardino, J. J. et al. | 2013
- A691
-
Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes MellitusKhan, M. S. / Akhtar, N. / Ali, A. et al. | 2013
- A692
-
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in ChileGarcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Garay Ulises, U. / McMullen, M. / Rey Ares, L. / Peirano, I. / Oksenberg Reisberg, D. / Soza Ried, A. / Poniachik, J. et al. | 2013
- A693
-
Evaluation of Factors Affecting Treatment Response and Risk Factors for Patients Diagnosed with Non-Psychotic Major Depressive Disorder: A Literature ReviewGreene, N. / Greene, M. et al. | 2013
- A694
-
The Impact of Antipsychotics Polypharmacy on Health Care Costs of People with Mental Disorders in São Paulo City, BrazilRazzouk, D. / Sousa, A. / Oliveira, G. G. / Cardoso, A. / Mari, J. J. et al. | 2013
- A695
-
Contribution of Latin America to Mental Health in PregnancyLorenzo, L. S. / Einarson, A. / Einarson, T. R. et al. | 2013
- A696
-
Costo-Efectividad Del Screening Y Tratamiento De Hipoacusia Bilateral En Recién Nacidos (Rn) En ChileCastillo-Laborde, C. / Loayza, S. / Aravena, M. / Freile, B. / Castillo-Riquelme, M. et al. | 2013
- A697
-
Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De TrasplantesRosselli, D. / Rueda, J. D. / DÃaz, C. E. et al. | 2013
- A698
-
Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Compared to Basiliximab in the Induction of Renal Transplant PatientsEscudero, P. / Misas, J. D. / Orozco-Cabal, L. F. et al. | 2013
- A699
-
Estudios Del Coste De La EnfermedadCrespo, C. / Gisbert, R. / Brosa, M. et al. | 2013
- A700
-
Analysis of Mandibular Test Specimens Used to Evaluate Bone Fixation SystemsPasseri, L. A. / Baccarin, L. S. / Casarin, R. C. / Silva, J. V. et al. | 2013
- A701
-
Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En ReumatologÃa: Uso De Los Estudios EconómicosGuzman Vazquez, S. / Rodriguez Mendoza, M. M. / Pizarro, M. / Soto, H. et al. | 2013
- A702
-
Permanent Transvenous Lead Extraction: Factors Influencing the Difficulty of the ProcedureBontempi, L. / Cerini, M. / Lipari, A. / Vassanelli, F. / Salghetti, F. / Locantore, E. / Belotti, M. / D’Aloia, A. / Vizzardi, E. / Raweh, A. et al. | 2013
- A703
-
Analysis of Consumption of Antihypertensive Drugs in Serbia from 2007 to 2011Milijasevic, B. / Milijasevic, D. / Tomic, Z. / Sabo, A. / Mikov, M. / Tomic, N. et al. | 2013
- A704
-
Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting in Mexico CityRely, K. / RamÃrez-Neria, P. / Pulido, T. / Escamilla, C. / Alexandre, P. K. / Cañedo, A. / Salinas Escudero, C. et al. | 2013
- A705
-
Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care SystemNishikawa, A. M. / Paladini, L. / Borges, L. / Queiroga, M. / Lemos, P. / Clark, O. A. et al. | 2013
- A706
-
Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento CardiovascularSimbaqueba, E. / Romero, M. et al. | 2013
- A707
-
Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico: A Comparison to SwedenSemilla, A. P. / Kowal, S. / Storm, M. / Blanchard, T. et al. | 2013
- A708
-
Análise Comparativa Dos Anticoncepcionais Orais Com Diferentes Concentraçoes De Etinilestradiol Em Relação Aos Perfis De Eficácia E De AdesãoFreitas, M. G. / Silva, A. S. / Elias, F. T. et al. | 2013
- A709
-
Costo-Efectividad De Carbetocina En Comparación Con Oxitocina Para Prevenir Hemorragia Posparto Por AtonÃa Uterina En Pacientes Con Factores De Riesgo En ColombiaRueda, C. / Caceres, L. A. / Caicedo Navas, A. G. et al. | 2013
- A710
-
Measurements of Adherence to Oral Therapies Among Brazilian Patients: A Systematic ReviewTakemoto, M. L. / Guerra, R. / Fernandes, R. A. / Pereira, A. C. / Santos, P. M. / Amaral, L. M. / Vasconcellos, J. F. et al. | 2013
- A711
-
Atención Intercultural Del Parto Vaginal En México: Costos Económicos, Determinantes Y Retos De La Implementación De PolÃticas Efectivas En Beneficio De Las Mujeres IndÃgenasHeredia, I. / Meneses, S. / Montag, D. / Ibañez, M. / Hernández, E. / González Block, M. A. et al. | 2013
- A712
-
Costos Económicos Asociados A Secuelas De Meningitis En ColombiaAlvis-Guzmán, N. / Coronell-Rodriguez, W. / Castañeda-Orjuela, C. A. / De la Hoz-Restrepo, F. et al. | 2013
- A713
-
The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia: A Transmission Dynamic Model-Based EvaluationKothari, S. / Nwankwo, C. / Pillsbury, M. / Shcheprov, A. / Posso, H. et al. | 2013
- A714
-
Pharmacoeconomics of Cervarix Vaccines Against Human Papilloma Virus in the Republic of KazakhstanNurgozhin, T. / Gulyaev, A. / Yermekbayeva, B. / Kushugulova, A. / Akhmetova, A. / Supiev, A. et al. | 2013
- A715
-
Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012Reis, H. P. / Magalhães, D. D. / Vieira, J. B. / Sartori, D. P. / Fonseca, D. B. / Filho, A. E. / Barsi, U. D. / Gontei, M. / Alcantara, A. C. / Maciel, J. A. et al. | 2013
- A716
-
Custos Das Fraturas Osteoporóticas No Sistema Público De Saúde BrasileiroBrandão, C. M. / Machado, G. P. / Drumond, H. A. / Alemão, M. M. / Acurcio, F. D. et al. | 2013
- A717
-
Estimated Cost Effectiveness of Lower-Dose Submicron Diclofenac Compared with Traditional Diclofenac in BrazilMladsi, D. M. / Ronquest, N. / Tannus, G. / Fonseca, M. / Saag, K. et al. | 2013
- A718
-
Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, BrasilOliveira Junior, H. A. et al. | 2013
- A720
-
Burden of Multiple Sclerosis and Unmet Needs in Brazil: Cost of Illness StudySilva, N. L. / Takemoto, M. / Damasceno, B. / Fragoso, Y. D. / Finkelsztejn, A. / Gomes, M. et al. | 2013
- A721
-
Cost-Effectiveness Analyses of Natalizumab for 1st Line Versus Interferon Beta-1a 44 Mcg in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis Patients in BrazilNishikawa, A. M. / Paladini, L. / Liamas, A. L. / Bueno, C. C. / Clark, O. A. et al. | 2013
- A722
-
Evaluation of Treatment Patterns and Clinical Trials Published on Patients Diagnosed with Insomnia: A Literature UpdateGreene, N. / Greene, M. et al. | 2013
- A723
-
Health and Economic Burden of Tobacco Use in Seven Latin American Countries: Results from a Microsimulation Health Economic Model (HEM)Pichon Riviere, A. / Bardach, A. / Caporale, J. / Augustovski, F. / Alcaraz, A. / Navia, M. D. / Pinto, M. / Vallejos, C. / Peña Torres, E. / Reynales, L. M. et al. | 2013
- A725
-
Efficacy and Safety of Belimumab for the Treatment of Systemic Lupus ErythematosusBorba, H. H. / Wiens, A. / Correr, C. J. / Pontarolo, R. et al. | 2013
- A726
-
Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones ClÃnicas Mucocutáneas De La Enfermedad De BehcetQuirland Lazo, C. et al. | 2013
- A727
-
Orphan Drug Access: Risk/Reward Analysis of Local Clinical Development in ChileIsmail, A. / Dummett, H. et al. | 2013
- A729
-
ISPOR 4th Latin America Conference Disclosure Information| 2013
- A732
-
ISPOR 4th Latin America Conference Author Index| 2013
- i
-
Table of Contents| 2013
- I
-
Instructions for Authors| 2013
-
Cost-Effectiveness of the Systematic Identification and Treatment of Comorbid Major Depression for People with Chronic Diseases: The Example of CancerWalker, S. / Walker, J. / Richardson, G. / Palmer, S. / Wu, Q. / Gilbody, S. / Martin, P. / Holm Hansen, C. / Sawnhey, A. / Murray, G. et al. | 2013
-
A Cost-Utility Analysis of Everolimus Plus Exemestane for the Treatment of ER+ HER2- Metastatic Breast Cancer in the United KingdomTaylor, M. / Lewis, L. / Vieira, J. / Chandiwana, D. et al. | 2013
-
Quality of Life in Patients with Metastatic Colorectal Cancer (mCRC): A Utilities Study in the United Kingdom and the NetherlandsStein, D. / Joulain, F. / Iqbal, S. U. / Naoshy, S. / Muszbek, N. / Payne, K. A. / Ferry, D. R. et al. | 2013
-
Health Care Resource Utilization and Expenditures of Incident Breast Cancer Patients in the Netherlands: Retrospective Analysis of Health Insurance DataTariq, L. / Steins Bisschop, C. N. / Haj Mohammad, G. / Stricker, M. S. / de Wit, G. A. / van Rossum-Schornagel, Q. C. / Hövels, A. M. / Peeters, P. H. / May, A. M. et al. | 2013
-
Nurses’ Preferences for Bone Metastases Treatments in the United StatesMohamed, A. F. / Qian, Y. / Hauber, A. B. / Collins, H. / Hechmati, G. / Gatta, F. / Arellano, J. et al. | 2013
-
Efficacy and Safety of Treatments of Type 2 Diabetes Mellitus (T2DM): A Systematic Review (Slr)Pettré, S. / Selya-Hammer, C. / Ho, S. / Garg, M. / Schroeder, M. / Kaur, V. / Hemels, M. et al. | 2013
-
Pharmacoeconomic Peculiarities of Thyroid Disease Treatment in UkraineVadziuk, I. et al. | 2013
-
EVPI Curves in PracticeJeppsson, K. / Posnett, J. / Carlqvist, P. et al. | 2013
-
The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Glipizide in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and WalesCharokopou, M. / McEwan, P. / Lister, S. / Callan, L. / Bergenheim, K. / Tolley, K. / Roudaut, M. et al. | 2013
-
Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United KingdomChubb, B. / Evans, M. / Wolden, M. / Christensen, T. / Gundgaard, J. et al. | 2013
-
The Impact of Memory Problems on Diabetes Treatment in the United KingdomBrod, M. / Kongso, J. / Bushnell, D. M. et al. | 2013
-
Psychosocial Adjustment in Diabetic Patients with and without Diabetic Foot-Ulcers-A Comparative StudyPrabhu, V. A. / Doddapaneni, S. / Roy, R. T. / Rodrigues, G. S. / Unnikrishnan, M. K. / Sekhar, S. M. et al. | 2013
-
UTILITIES FOR TYPE 2 DIABETES MELLITUS AND ASSOCIATED COMPLICATIONSShingler, S. L. / Fordham, B. / Evans, M. / Thompson, G. / Schroeder, M. / Lloyd, A. J. et al. | 2013
-
Patients Preferences Regarding the Treatment of Type II Diabetes Mellitus: Comparison of Best-Worst Scaling and Analytic Hierarchy ProcessMühlbacher, A. C. / Bethge, S. / Kaczynski, A. / Juhnke, C. et al. | 2013
-
Validation of the WHOQOL-OLD in TaiwanYao, G. / Chien, C. C. et al. | 2013
-
Self-Monitoring of Blood Glucose with Insulin Analogues: Nice to Have or Need to Have? Analysis of Phase III Registration Trials and European Public Assessment Reports of Insulin AnaloguesCaruso, A. / Hilsdorf, H. L. / Mast, O. et al. | 2013
-
UK Quality Outcomes Framework (QOF) Thresholds and Elevated HbA1c Levels Among Patients with Type II Diabetes - A Longitudinal Study Using the Clinical Practice Research Datalink (CPRD)Jameson, K. / D’Oca, K. / Murray-Thomas, T. / O’Regan, C. / Leigh, P. et al. | 2013
-
Treatment Patterns and Burden of Illness of Cushing’s Disease in the United Kingdom: Real World (RW) Data from Clinical Practice Research Datalink (CPRD)Murray, R. D. / Forsythe, A. / Siva, V. / Oliver, N. / Rojas-Farreras, S. / Roset, M. et al. | 2013
-
Quality of Care for Type 2 Diabetes Mellitus Patients in DubaiDonato, B. M. / Osenenko, K. M. / Korol, E. E. / Szabo, S. M. / Qatami, L. / Al Madani, A. / Al Awadi, F. / Al Ansari, J. / Maclean, R. / Levy, A. R. et al. | 2013
-
Medico-Economic Evaluation in France: Methodology and Impact on the Pricing and Reimbursement SystemFuret, J. / Marinoni, G. / Ando, G. et al. | 2013
-
Does Europe Reward Reformulations? A Data Driven Analysis of Value Preservation Through ReformulationHughes, A. L. / Luft, D. / Lions, I. / Flostrand, S. J. et al. | 2013
-
Croatia’s EU Accession in the Context of International Reference Pricing: What Will Be the Wider Impact for Pricing and Reimbursement?Melck, B. / Izmirlieva, M. / Ando, G. et al. | 2013
-
The Hybrid Purchaser-Provider Split in England: Should Europe Follow Suit?Sewak, N. P. / Devienne, E. / Karia, R. et al. | 2013
-
Models of Drug Safety Monitoring in England, Poland, Italy, Germany, Denmark and United StatesHermanowski, T. R. / Krancberg, A. N. / Szafraniec-Burylo, S. I. et al. | 2013
-
Specific Attributes of Pharmaceutical Care in England, Poland, Germany, Denmark, Italy and United StatesHermanowski, T. R. / Duleba, D. / Krancberg, A. N. / Szafraniec-Burylo, S. I. / Pashos, C. L. et al. | 2013
-
Analysis of Adverse Reactions of Medicine in UkraineZalis’ka, O. / Maksymovych, N. / Zaliskyy, O. et al. | 2013
-
A 10-Year Review of the Canadian Common Drug Review: Pharmaceutical Manufacturers’ Success RateShum, D. / Wyatt, G. / Siu, E. / Mills, F. et al. | 2013
-
Investigating the Economic Impacts of New Public Pharmaceutical Policies in GreeceSiskou, O. / Litsa, P. / Georgiadou, G. / Paterakis, P. / Alexopoulou, E. / Argyri, S. / Kaitelidou, D. / Liaropoulos, L. et al. | 2013
-
Drivers of Clinician Prescribing Decisions and the Economics of InformationParkinson, B. / Viney, R. / Goodall, S. / Haas, M. et al. | 2013
-
Impact of Reimbursement of Medicines on Economic Accessibility Level for Working Population in Republic of MoldovaChitan, E. / Brumarel, M. et al. | 2013
-
Assessment of Methodological Quality of Economic Evaluations in Belgian Drug Reimbursement ApplicationsSimoens, S. et al. | 2013
-
Personalized Health Care in France, Germany and the United Kingdom: Are Health Technology Assessment Agencies Ready?Walzer, S. / Gartemann, J. / Zoellner, Y. F. / Towse, A. / Garrison, L. et al. | 2013
-
Astrological Signs and Health Problems; Demonstrating the Multiple Comparisons ProblemVegter, S. / van Boven, J. F. / Pechlivanoglou, P. / Rozenbaum, M. H. / Stevanovic, J. / Le, H. H. et al. | 2013
-
Pharmacoeconomic Education for Health Care Students in Bosnia and HerzegovinaCatic, T. et al. | 2013
-
Analysis and Classification of Risk-Sharing Schemes Proposed in Reimbursement Application Received by AHTAPol in 2012Zawodnik, S. / Iwanczuk, T. / Hermanowski, T. / Matusewicz, W. et al. | 2013
-
HTA National Public Policy and Their Socio-Economic Environment: A European PerspectiveBenoit, C. / Gorry, P. et al. | 2013
-
Comparing the Value of Different HTA Decision Making Process: Evaluating the EvaluatorsJohannesen, K. M. / Claxton, K. / Sculpher, M. J. / Wailoo, A. J. et al. | 2013
-
A Choice of Business for the Pharmaceutical Industry “Seguro Popular†in MexicoVilchis, S. et al. | 2013
-
Diagnosis of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis, Pancreatic Cancer and Gastrointestinal or Pancreatic Surgery Patients: A Systematic Literature Review and Expert Consensus on the Accuracy of Diagnostic Test Used in SpainDe Madaria, E. / Gonzalez-Carro, P. / Boadas, J. / Puig de la Bellacasa, J. / Carr, E. / Labrador, E. / Paz, S. / Lizán, L. / Schwander, B. / Dominguez, M. u. et al. | 2013
-
Enteral Diets (ED): A Cost-Comparison Analysis for In-Hospital Preparations Based on Real World ObservationClark, O. A. / Paladini, L. / Nishikawa, A. M. / Borges, L. / Arraiz, A. et al. | 2013
-
Cost-Effectiveness of Linaclotide Compared to Antidepressants in the Treatment of Irritable Bowel Syndrome with Constipation in ScotlandFisher, M. / Falqués, M. / Rance, M. / Taylor, D. C. / Lindner, L. et al. | 2013
-
How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug BudgetLanati, E. P. / Lidonnici, D. / Cammà , C. et al. | 2013
-
Patient Preferences Regarding Monitoring and Treatment for the Management of Neovascular Age-Related Macular DegenerationFerreira, A. / Lall, A. / Squire, A. / Gregg, L. / Graham, A. et al. | 2013
-
Hemangioma Family Burden: Creation of a Specific QuestionnaireTaieb, C. / Boccara, O. et al. | 2013
-
Physician Experience with Rituximab to Treat Pemphigus Vulgaris in Canada: A Questionnaire-Based StudyMittmann, N. / Knowles, S. / Heelan, K. / Bannon, G. / Seung, S. J. / Shear, N. et al. | 2013
-
Waiting Times and Scheduling in Dermatological Practices in GermanyKrensel, M. / Augustin, M. / Reusch, M. / Rosenbach, T. et al. | 2013
-
Health Related Quality of Life-Outcome in National Care - Real World Data from the German Psoriasis-Registry “Psobestâ€Purwins, S. / Spehr, C. / Augustin, M. / Radtke, M. A. / Reich, K. / Rustenbach, S. J. et al. | 2013
-
Application of Logistic Regression for Signal Detection and Risk Assessment of Macrolide-Associated Torsade De PointesAli, A. K. et al. | 2013
-
An Analysis of the Cost Effectiveness of Left Atrial Appendage Closure for the Prevention of Stroke in Patients with Atrial Fibrillation and Absolute Contraindications to Warfarin TherapyReddy, V. Y. / Akehurst, R. L. / Amorosi, S. L. / Armstrong, S. / Holmes, D. R. et al. | 2013
-
Issues with Cost-Effectiveness Modelling of Diagnostic Tests – Case Study of Ischaemic CardiomyopathyThokala, P. / Thomas, S. / Campbell, F. et al. | 2013
-
Screen or Not to Screen for Peripheral Arterial Disease: Guidance from a Decision ModelVaidya, A. / Joore, M. A. / tenCate-Hoek, A. J. / tenCate, H. / Severens, J. L. et al. | 2013
-
Cost Utility Analysis of Screening and Treatment of Hyperlipidemia in Chinese Adults Aged 45 and AboveZhang, X. G. / Wu, J. J. / Chen, C. I. / Xie, X. P. / Liu, L. / Yang, L. et al. | 2013
-
Lifetime Cost-Effectiveness of Isolated and Concomitant Aortic Valve Replacements in GermanyPradelli, L. / Giardina, S. / Ranucci, M. et al. | 2013
-
Stroke Prevention in Non-Valvular Atrial Fibrillation: Systematic Review of Cost-Effectiveness StudiesCosta, S. / Ramos, J. C. / Braga, A. C. / Pereira, J. et al. | 2013
-
Pharmacoeconomic Analysis of Ivabradine Use in BelarusKozhanova, I. / Romanova, I. / Gavrilenko, L. / Sachek, M. et al. | 2013
-
Health State in Patients with Atrial Fibrillation on New Oral Anticoagulants as Assessed with the New EQ-5D-5L Questionnaire: Prefer in AF RegistryBrüggenjürgen, B. / Ammentorp, B. / Darius, H. / De Caterina, R. / Le-Heuzey, J. Y. / Pittrow, D. / Reimitz, P. E. / Schilling, R. J. / Schwertfeger, M. / Zamorano, J. L. et al. | 2013
-
Compliance with Preventive Recommendations in Primary Care and Rate of Potentially Avoided Hospitalizations by Diabetes, Chronic Heart Failure or Chronic Pulmonary Obstructive DiseaseAizpuru, F. / Latorre, A. / Ibañez, B. / López-Picado, A. / Millan, E. et al. | 2013
-
Impact of Switching on Health Care Costs and Outcomes in Generic Drug PoliciesKalo, Z. / Abonyi-Tóth, Z. / Rokszin, G. / Katona, L. / �gh, T. / Inotai, A. et al. | 2013
-
The Short-Term Impact of Particulate Matter Exposure on the Risk of Prescription of Cardiorespiratory Drugs in ItalyConti, S. / Lafranconi, A. / Fornari, C. / Madotto, F. / Cesana, G. et al. | 2013
-
Psychoactive Drug Use, Polypharmacy and Co-Morbidities in Newly Diagnosed Patients with Pervasive Development Disorder in the Province of QuebecCroteau, C. / Dorais, M. / Tarride, J. E. / Mottron, L. / Perreault, S. et al. | 2013
-
Meta-Analysis of Efficacy of Etanercept for Treatment of Psoriatic ArthritisAggarwal, S. / Topaloglu, H. et al. | 2013
-
Improvement in Disease Activity Scores Associated with Early Versus Late Initiation of Biologic Therapy in Patients with Rheumatoid Arthritis: Results of a European Chart Review StudyEmery, P. / Solem, C. T. / Macahilig, C. P. / Majer, I. M. / Stephens, J. M. / Cappelleri, J. C. / Tarallo, M. et al. | 2013
-
Systematic Review Comparing the Efficacy and Safety of Collagenase Clostridium Histolyticum (Xiaflex®) Injection with Surgical Fasciectomy for the Treatment of Dupuytren’s ContractureSugden, P. / Cottrell, S. / Tilden, D. / Ballmer, A. et al. | 2013
-
Annual Expenditure on Anti-Tnf Treatment of Rheumatoid Arthritis for the Public Health System in BrazilNobre, M. R. / Costa, F. M. / Taino, B. / Kiyomoto, H. D. / Rosa, G. F. et al. | 2013
-
Pharmacotherapeutic Monitoring of Patients Using Immunobiological in a Health Insurance Company in Brazil: To Know to Better ManageReis, H. P. / Vieira, J. B. / Fonseca, D. B. / Magalhães, D. D. / Sartori, D. P. / Viana, A. D. / Barsi, U. D. / Alencar, J. L. / Maciel, J. A. / Filho, A. E. et al. | 2013
-
Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in FranceFagnani, F. / Pham, T. / Claudepierre, P. / Berenbaum, F. / De Chalus, T. / Saadoun, C. / Joubert, J. M. / Fautrel, B. et al. | 2013
-
Tocilizumab in Polyarticular Juvenile Idiopathic Arthritis – A Cost-Utility Model for the United KingdomChang, S. / Sawyer, L. / Dejonckheere, F. / van Suijlekom-Smit, L. W. / Anink, J. / Diamantopoulos, A. et al. | 2013
-
Costs of Hormonal Receptor Positive, Her 2 Negative Metastatic Breast Cancer (MBC-HR+) in Brazilian Private System (BPS): A Real World and Published Literature AnalysisClark, O. A. / Paladini, L. / Engel, T. / Nishikawa, A. M. / Borges, L. / Caldas, A. / Valentim, J. et al. | 2013
-
Long-Term Cost Comparison Between Paricalcitol and Calcitriol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in MexicoSanchez-Casillas, J. L. / Ramirez-Lopez-De-N, M. G. et al. | 2013
-
Ruling Out IBD in the United Kingdom and Brazil: Is the Usage of F-Calprotectin in Primary Care Cost-Effective?Mascialino, B. / Hermansson, L. L. / Larsson, A. et al. | 2013
-
Evaluación De Costo-Efectividad De La Trabeculoplastia Láser Selectiva Como Primera Opción De Tratamiento En Glaucoma Primario De Ãngulo Abierto En ColombiaBernal, M. M. / Organista, J. / Rico, A. / Romero, M. / Barrero, J. R. et al. | 2013
-
Análisis De Minimización De Costos Del Uso Del Aflibercept En Degeneracion Macular Relacionada Con La Edad En ColombiaRomero, M. / Huerfano, L. / Acero, G. et al. | 2013
-
Frecuencia Y Costos De Hospitalización En Una Población De Pacientes En Dialisis En ColombiaSanabria, M. / Astudillo, K. / Sanchez, R. / Camargo, D. / Bunch, A. et al. | 2013
-
Medición De La Calidad De Vida Por Medio Del “Dermatology Life Quality Index†En Pacientes Con Psoriasis: Una Revisión SistemáticaOrdoñez Molina, J. E. / Palacios Barahona, A. U. / Londoño Garcia, A. M. / Jimenez Tamayo, S. B. et al. | 2013
-
A Unified Methodological Framework for the Economic Evaluation of Therapeutic Medical DevicesIglesias, C. P. et al. | 2013
-
Costs and Consequences of Oral Anticoagulation in Atrial Fibrillation in ColombiaRosselli, D. / Rueda, J. D. / GarcÃa, A. / Rodriguez-Morales, A. J. / Garrido Lecca, S. / Vargas Zea, N. / Mould, J. F. / Donato, B. M. / Juarez Garcia, A. et al. | 2013
-
Approaches for Estimating Burden of Pneumococcal and Rotavirus Diseases: Conceptual Framework and Systematic ReviewGarcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Ciapponi, A. / Bardach, A. / Sinha, A. / Augustovski, F. et al. | 2013
-
Impacto En La Productividad Laboral De Una Cohorte De Pacientes Con Artritis Reumatoide Tratados Con Etanercept (Enbrel®) En ColombiaJauregui, E. / Upegui, A. / Romero, M. / Mantilla, R. / Maldonado, M. C. / Gonzalez, A. / Dominguez, A. / Valero, Y. / Morales, C. / Trouchon, M. C. et al. | 2013
-
Estimación De La Prevalencia De Artritis Reumatoide En MéxicoGalindo-Suárez, R. M. / Peniche-Otero, G. / Herrera-Rojas, J. / Gryzbowski, E. / Muciño-Ortega, E. / Aguirre, A. et al. | 2013
-
Clinical and Economic Analysis of Mometasone Furoate Nasal Spray in the Treatment of Rhinosinusitis in MexicoRely, K. / Blandon, V. / Fonseca, A. / Cañedo, A. / Salinas, G. E. / Alexandre, P. K. et al. | 2013
-
Biological Agents in the Treatment of Moderate to Severe Psoriasis: A Pharmacoeconomic AnalysisRiveros, B. S. / Souza, T. T. / Godoy, R. R. / Garcia, M. / Gonçalves, P. / Rotta, I. / Otuki, M. F. / Pontarolo, R. / Correr, C. J. et al. | 2013
-
Impact of Exclusive Hospital Distribution of Biosimilar on Drug Health Care BudgetRémuzat, C. / Vataire, A. L. / Cetinsoy, L. / Aballea, S. / Toumi, M. et al. | 2013
-
Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care ContextSiebert, U. / Sroczynski, G. / Baker, P. / Borget, I. / Castellsagué, X. / Chapman, R. / von Knebel-Doeberitz, M. / Mortensen, G. L. / La Torre, G. et al. | 2013
-
Patterns of Generic and Proprietary Prescribing of Statins Over Time in EnglandLeonard, S. A. / Wilson, T. J. / Hamerslag, L. et al. | 2013
-
Market Access of Implantable Medical Devices: Evidentiary Requirements Across Global MarketsChawla, A. S. / Spinner, D. S. / Ransom, J. F. / Doyle, J. / Faulkner, E. C. et al. | 2013
-
Price Differences Triggered by the Availability of Biosimilars in Developed CountriesReinaud, F. / Ando, G. et al. | 2013
-
Decison Making Under Uncertainty: Coverage with Evidence Development in the Context of Medical DevicesSorenson, C. / Drummond, M. et al. | 2013
-
Determinants of Non-Adherence to Medications Among Chronic Patients in Maccabi Health Care ServicesSimon Tuval, T. / Triki, N. / Chodick, G. / Greenberg, D. et al. | 2013
-
Impact of Highly Active Antiretroviral Therapy (HAART) Regimen on Adherence and Risk of Hospitalization in Veterans with HIV/AIDSRao, G. A. / Sutton, S. S. / Hardin, J. / Bennett, C. / Bramley, T. / D’Souza, A. O. et al. | 2013
-
Cost Reduction Associated with Use of Subglottic Aspiration to Reduce Ventilator-Associated Pneumonia in TurkeyKockaya, G. / Erslon, M. G. / Can, H. / Akin, O. / Ozcan, S. et al. | 2013
-
Pertussis in Brazilian Children: Mortality, Length of Stay, and Costs in Hospitalized PatientsFernandes, R. A. / Haas, L. C. / Takemoto, M. / Silva, M. A. / Vasconcellos, J. F. / Amaral, L. M. / Menezes, L. P. et al. | 2013
-
A Systematic Review of Economic Evidence in Hepatitis C: An Overview of Cost, Utility and Cost-Effectiveness DataWoods, M. S. / Kiri, S. / Ling, C. / McCrink, L. / Zimovetz, E. / Hass, B. et al. | 2013
-
Recent Trends in Hospital Costs, Length of Stay, and Mortality Associated with Pediatric Meningococcal Disease in the United StatesDavis, K. L. / Candrilli, S. D. et al. | 2013
-
The Burden of Clostridium Difficile in Spain: A Retrospective Matched-Cohort StudyHart, W. M. / Asensio, A. / Isidoro, B. / Watt, M. / Nazir, J. et al. | 2013
-
Cost and Length of Stay Associated with Vancomycin-Induced NephrotoxicityStevens, V. / Yoo, M. / Brown, J. et al. | 2013
-
Cost-Effectiveness of Childhood Rotavirus Vaccination in GermanyAidelsburger, P. / Grabein, K. / Boehm, K. / Helbig, A. K. / Dietl, M. / Wasem, J. / Koch, J. / Ultsch, B. / Weidemann, F. / Wichmann, O. et al. | 2013
-
Cost-Effectiveness Analysis of Stribild Compared to Similar Antiretroviral Therapies in a Specialty Retail PharmacyGriggs, S. K. / Davelis, M. et al. | 2013
-
Cost-Effectiveness of Antimicrobials as Treatment for Patients with Complicated Skin and Soft Tissues Infections: A Comparison Between Ceftaroline, Linezolid and Vancomycin in the Russian Health CareKulikov, A. / Komarov, I. et al. | 2013
-
Boceprevir Use in France: A Markov Model of Disease Progression and Cost-Effectiveness for Chronic Hepatitis C (Virus G1)Ferrante, S. / Elbasha, E. H. / Poynard, T. / Boyaval, G. et al. | 2013
-
Cost-Utility Analysis of Posaconazole Versus Fluconazole for Prevention of Invasive Fungal Infections in Patients with Graft-Versus-Host Disease in SwedenLundberg, J. G. / Jensen, A. V. / Bjorkholm, M. / Hoglund, M. / Akerborg, O. et al. | 2013
-
Health Care Resource Utilization and Adherence to Antiretroviral Treatment (ART) by HIV Patients: An Analysis with the Quebec (Canada) Public Drug Plan DatabaseLachaine, J. / Baril, J. G. / Lambert-Obry, V. / Beauchemin, C. et al. | 2013
-
An Assessment of Unemployment Among People Living with HIV/AIDS in Canada and EuropeCline, S. K. / Wang, S. / Van Wyk, J. / Baran, R. W. / Gooch, K. L. et al. | 2013
-
Assessing the Fiscal Consequences of Immunizing the Female and Male Population Against Human Papillomavirus (HPV) in GermanyKotsopoulos, N. / Connolly, M. / Remy, V. et al. | 2013
-
Current Characteristics, Treatment and Health Care Consumption of Patients with Asthma or COPD in the NetherlandsOverbeek, J. A. / Driessen, M. T. / Penning-van Beest, F. J. / Rutten-van Mölken, M. / Lammers, J. W. / Herings, R. M. et al. | 2013
-
Potential of Omega-3 Fatty Acid in Parenteral Nutrition in Germany: A Budget Impact AnalysisPradelli, L. / Povero, M. et al. | 2013
-
Pharmacoeconomic Assessment of Different Tactics of COPD Treatment in RussiaBelevskiy, A. S. et al. | 2013
-
Effect of Smoking Status on Health Care Costs and Resource Utilization in Patients with Chronic-Obstructive-Pulmonary-Disease in Clinical Practice: A Retrospective Nested Case-Control Economic StudySicras-Mainar, A. / Rejas, J. / Navarro-Artieda, R. / Ibañez, J. et al. | 2013
-
Cost-Effectiveness Analysis of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk Late Preterm Infants in the NetherlandsLangenfeld, M. K. / Visser, S. et al. | 2013
-
How Do Patients with Chronic Obstructive Pulmonary Disease (COPD) Use Their Inhalers? Common Mistakes. Tecepoc StudyLeiva-Fernandez, F. / Leiva-Fernandez, J. / Porcel-Martin, C. / Prados-Torres, D. / GarcÃa-Ruiz, A. J. / Barnestein-Fonseca, P. et al. | 2013
-
Tecepoc Study. How to Improve the Inhalation Techniques in Patient with COPD. The Influence of PreferencesLeiva-Fernandez, F. / Leiva-Fernandez, J. / Porcel-Martin, E. / Vazquez-Alarcon, R. / Martos-Crespo, F. / Barnestein-Fonseca, P. et al. | 2013
-
The Budget Impact of Qutenza® for the Treatment of Neuropathic Pain in SwedenChambers, C. / Nordling, S. / Smith, D. / Bentley, A. et al. | 2013
-
Potential Financial Impact of Sugammadex in Anaesthetic Departments: A Budget Impact Analysis on Potentially Short Procedures Requiring Neuromuscolar BlockadePovero, M. / Pradelli, L. et al. | 2013
-
Cohort Analysis Assessing Health Care Costs Associated with Obesity at Various Places of Service in Employed AdultsAbouzaid, S. / Kleinman, N. L. / Andersen, L. / Wang, Z. / Powers, A. et al. | 2013
-
Cost of Illness of Neuropathic Pain in Spain in 2012 from a Societal PerspectiveRuiz, L. / Liedgens, H. / Obradovic, M. et al. | 2013
-
A Cost-Utility Analysis of Lighterlife Total as a Treatment for Obesity in the United KingdomLewis, L. / Taylor, M. et al. | 2013
-
Cost-Effectiveness of School-Based Health Promotion in Canada: A Life-Course Modeling ApproachTran, B. / Ohinmaa, A. / Kuhle, S. / Johnson, J. A. / Veugelers, P. et al. | 2013
-
Evolution of Molecular Diagnostic Test Usage in Solid Tumours in Western Europe: Ambition Study (Analysis of Molecular Biomarker Tests in Oncology)Ricarte, C. / Bruce, A. / Anger, C. et al. | 2013
-
Targeted Therapy in Triple-Negative Metastatic Breast Cancer (TNBC) - A Systematic Review and Meta-AnalysisClark, O. A. / Engel, T. / Paladini, L. / Ferreira, M. B. et al. | 2013
-
Abiraterone and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post Chemotherapy: An Indirect Comparison and Budget Impact AnalysisLi, T. / Thompson, M. / Todd, M. / Yu, M. / Kheoh, T. / Saadi, R. et al. | 2013
-
Estimating and Modeling Long Term Survival in Lung Cancer Using Mixture Parametric ModelsSánchez, L. / Luaces, P. / Viada, C. / Galan, Y. / Ballesteros, J. / RodrÃguez, P. C. / Crombet, T. / Lage, A. et al. | 2013
-
Budget Impact of Lipegfilgrastim for the Management of Chemotherapy-Induced NeutropeniaMontouchet, C. / Ruff, L. / Cerchiari, A. / Plich, A. et al. | 2013
-
Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine Compared to Other Regimens in the Canadian Health Care SystemPiwko, C. / Prady, C. / Yunger, S. / Moser, A. / Le, P. / Vicente, C. et al. | 2013
-
A Critical Appraisal of Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening: Making Appropriate Comparisons and Usefully Interpreting ResultsO’Mahony, J. / Naber, S. / de Kok, I. M. et al. | 2013
-
Comparative Study of the Cost-Effectiveness of Trastuzumab in the Treatment of Breast Cancer in Different CountriesRabbani, S. / Ardam, A. / Salamzadeh, J. et al. | 2013
-
The Potential Cost-Effectiveness of Obinutuzumab (Ga101) in Combination with Chlorambucil in Chronic Lymphocytic LeukemiaWalzer, S. / Becker, U. / Samanta, K. / Wiesner, C. / Mueller, E. et al. | 2013
-
Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: A UK Cost-Effectiveness AnalysisBester, L. / Wasan, H. / Sangro, B. / Kennedy, A. / Pennington, B. / Sennfält, K. et al. | 2013
-
Cost-Utility Analysis of Tocilizumab in Combination with Methotrexate Versus Standard of Care for the Treatment of Rheumatoid Arthritis in GreeceAthanasakis, K. / Konstantopoulou, T. / Tarantilis, F. / Tsalapati, K. / Vritzali, E. / Kyriopoulos, J. et al. | 2013
-
High Economic Burden of Moderate to Severe Psoriatic Arthritis on Paid Work and Household Productivity: Baseline Results from the Rapid-PSA StudyKavanaugh, A. / Mease, P. J. / Purcaru, O. / van der Heijde, D. et al. | 2013
-
The Use of Dexa Scans in Postmenopausal Osteoporosis Is Associated with Reduced Long Term Fracture RiskBurke, T. P. / de Courcy, J. / Milligan, G. et al. | 2013
-
Patient Preference for Oral Versus Injectable and Intravenous Methods of Treatment for Rheumatoid ArthritisBarclay, N. / Tarallo, M. / Hendrikx, T. / Marett, S. et al. | 2013
-
Long-Term Maintenance of Improvements in Patient-Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 48-Week Results of the Rapid-axSpA StudySieper, J. / Kivitz, A. / van Tubergen, A. / Deodhar, A. / Coteur, G. / Singh, P. / Landewé, R. et al. | 2013
-
Cost-Effectiveness Analysis of Alendronate Therapy for Secondary Prevention of Osteoporotic FracturesMoriwaki, K. / Komaba, H. / Noto, S. / Yanagisawa, S. / Takiguchi, T. / Toujo, T. / Inoue, H. / Fukagawa, M. / Takahashi, H. E. et al. | 2013
-
Rationale for Initiating and Switching Biologic Therapy in Patients with Rheumatoid Arthritis: Results of a European Chart Review StudyEmery, P. / Solem, C. T. / Macahilig, C. P. / Corman, S. / Majer, I. M. / McGuire, M. / Cappelleri, J. C. / Tarallo, M. et al. | 2013
-
Design of a Randomized Controlled Trial (RCT) Evaluating Outcome and Cost-Effectiveness of a Local Case Management Intervention of Patients Suffering from Chronic Obstructive Pulmonary Disease (COPD)Sørensen, S. S. / Pedersen, K. M. / Ehlers, L. et al. | 2013
-
An Excel Calculator to Estimate Rheumatoid Arthritis Costs in TurkeyBaser, O. / Burkan, A. / Baser, E. / Koselerli, R. / Ertugay, E. / Altinbas, A. et al. | 2013
-
Applicability of Japanese Health Care Database to Clinical Trial Planning for Dyslipidaemia DrugYamamoto, Y. / Nagayasu, S. / Tomosugi, T. / Matsuoka, N. / Takata, A. / Kanmuri, K. / Imai, K. / Fujimoto, Y. et al. | 2013
-
The Cost-Effectiveness of Sequential First- and Second-Line Treatments in Metastatic Renal Cell Carcinoma Using Real-World Data and a Patient-Level Simulation Modelde Groot, S. / Blommestein, H. / Redekop, W. / Oosterwijk, E. / Kiemeney, L. / Uyl- de, G. r. et al. | 2013
-
Extrapolating Survival in a Heterogeneous Patient Population with Metastatic Melanoma; A Case Study of Integrating Statistical and Clinical ConsiderationMajer, I. M. / Gueron, B. / Kotapati, S. / Van Hout, B. et al. | 2013
-
Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response TheoryGupta, S. / DiBonaventura, M. et al. | 2013
-
Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice SettingsSchneider, M. / Mosca, M. / Pego-Reigosa, J. M. / Koscielny, V. / Moore-Ramdin, L. / Devilliers, H. et al. | 2013
-
Quantifying Health Care Efficiency: A Review of Published Time and Motion Study Design Parameters Referenced in Pubmed Between 2008-2013Kritikou, P. / Bassel, M. / De Cock, E. / Payne, K. A. et al. | 2013
-
An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-SettingStandaert, B. / Ethgen, O. / Emerson, R. A. / Postma, M. J. et al. | 2013
-
Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal ProductsPrieto, L. / Hidalgo-Simon, A. / Arlett, P. et al. | 2013
-
Disease Burden in Epilepsy Associated with Tuberous Sclerosis Complex: Systematic ReviewBlieden, M. / Parker, L. / Foster, T. / Segal, S. / Magestro, M. et al. | 2013
-
Clinical Effectiveness of Lacosamide and Its Impact on Concomitant Antiepileptic Drugs Consumption in the Czech RepublicKlimes, J. / Vocelka, M. / Dolezal, T. / Foitova, H. et al. | 2013
-
Budget Impact of Switching Pramipexole Immediate Release to Pramipexole Extended Release in Treatment of Parkinson’s Disease; Perspective of the Social Security InstitutionKececioglu, S. / Ulus, P. / Cukadar, F. / Urganci, B. / Ozkan, M. et al. | 2013
-
Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx StudyDarba, J. / Kaskens, L. / Sánchez-de la, R. o. et al. | 2013
-
Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 Mcg for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in BrazilNishikawa, A. M. / Paladini, L. / Liamas, A. L. / Bueno, C. C. / Clark, O. A. et al. | 2013
-
Disease Burden Among Patients with Secondary Progressive Multiple Sclerosis Currently Using Disease Modifying Treatments in Europe Union and the United StatesNarayanan, S. / Khan, H. / Gabriele, S. / White, J. et al. | 2013
-
The Cost Implications of Renal Denervation Therapy at the Hospital Level in the United KingdomSmith, T. A. / de Silva, S. U. / Firth, Z. A. / Cuche, M. R. / Bending, M. W. et al. | 2013
-
Economic Evaluation of Pharmacological Treatments for Overactive BladderPosnett, J. / Walker, A. / Nazir, J. / Odeyemi, I. A. / Hakimi, Z. / Garnham, A. et al. | 2013
-
Cost-Minimization Analysis of Ferumoxytol in the Management of Anemia in Patients with Chronic Kidney Disease in BelgiumVandekerckhove, S. / Lamotte, M. / Petit, C. et al. | 2013
-
Time Savings with Once-Monthly C.E.R.A.: A Time and Motion Study Conducted in 13 Hemodialysis Centres in ItalyDe Cock, E. / Kritikou, P. / Proskorovsky, I. / Tomic, R. et al. | 2013
-
National Spending with Screening, Diagnosis and Treatment of Cervical Cancer: Estimates Based on Health Information Systems, Brazil, 2006Novaes, H. M. / De Soarez, P. C. / Itria, A. / azevedo e Silva, G. / Sartori, A. M. / Rama, C. et al. | 2013
-
Análisis Costo-Efectividad De Linezolid Comparado Con Vancomicina En El Manejo De La NeumonÃa Asociada A La Ventilación Mecanica En ColombiaVaron, F. A. / Londoño, D. / Ã�lvarez, C. / Taborda, A. / Prieto Martinez, V. et al. | 2013
-
Economic Evaluation of an Urine Closed Collection System Versus a Traditional Open Device in Non-Pregnant WomenCardona, D. P. / Burbano-Levy, X. / Palacios, E. / Zapata, L. et al. | 2013
-
Argentina’s Generic Drug Law: Was It Successful?Lee, B. / Garay, O. U. / Goldhaber-Fiebert, J. / Tang, J. / Lightwood, J. / Wilson, L. S. et al. | 2013
-
¿Los Formularios Nacionales (Cuadros Básicos) Provocan Oligopolios E Incentivan a Tener Precios Altos?Lechuga, D. et al. | 2013
-
The Ecology of Medical Care in Poor Settings: Self Reported Health Care Utilization in Santiago Del Estero, ArgentinaInsua, J. T. et al. | 2013
-
What are the Key Drivers of Reimbursement for Biosimilars? An Examination of Reimbursement Processes and Recommendations Across Nine Countriesde Silva, S. U. / Smith, T. A. / Bending, M. W. et al. | 2013
-
Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5DKrabbe, P. F. / Devlin, N. J. / Stolk, E. A. / Shah, K. K. / Oppe, M. / van Hout, B. / Quik, E. H. / Pickard, A. S. / Xie, F. et al. | 2013
-
Investigating the Impact of Mental Health Status on Health and Social Care Costs of Older People after Acute Hospital AdmissionBerdunov, V. / Franklin, M. / Tanajewski, L. / Harwood, R. / Goldberg, S. / Gladman, J. / Elliott, R. A. et al. | 2013
-
Societal Burden of Hysterectomy in Reproductive-Aged Women with Uterine FibroidsVámossy, I. / �gh, T. / Blasszauer, C. / Bagó, M. / Mészáros, . / Kalo, Z. et al. | 2013
-
Public Health Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in FranceGerlier, L. / Lenoir-Wijnkoop, I. / Berdeaux, G. et al. | 2013
-
Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in ItalyIannazzo, S. / De Francesco, M. / Coco, B. / Brunetto, M. / Tomic, R. / Paolini, D. / Palmieri, G. / Bonino, F. et al. | 2013
-
Linezolid for the Treatment of Patients with Confirmed MRSA Nosocomial Pneumonia in Nanjing, China: A Cost Effective Alternative to VancomycinTan, S. C. / Li, Q. / Chen, Y. / Hájek, P. / Weinstein, D. / Patel, D. A. et al. | 2013
-
Cost-Effectiveness of Anti-Rabies Prophylaxis After Exposure to Unobservable Dogs in Eradication Context: The French CaseN’Diaye, D. S. / Ribadeau-Dumas, F. / Yazdanpanah, Y. et al. | 2013
-
Antibacterial Treatment of Meticillin-Resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections: A Cost-Effectiveness Analysis in GreeceKarampli, E. / Ollandezos, M. / Petrakis, I. / Tsoulas, C. / Patel, D. A. / Kyriopoulos, J. et al. | 2013